Adicet Bio, Inc. announces a board member resignation and the appointment of Michael Grissinger, reflecting ongoing leadership changes in the pharmaceutical sector.
| Name | Adicet Bio, Inc. |
|---|---|
| CIK | 0001720580 |
| Tickers | ACET |
| Exchanges | Nasdaq |
| Entity type | operating |
| Category | Non-accelerated filer<br>Smaller reporting company |
| SIC | 2834 Pharmaceutical Preparations |
| EIN | 813305277 |
| LEI | — |
| Fiscal year end | 1226 |
| State of incorporation | DE DE |
| Phone | 617-482-2333 |
| Website | — |
| Investor website | — |
| Owner org | 03 Life Sciences |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 1 |
| Insider transactions (owner) | 0 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
Adicet Bio, Inc. announces a board member resignation and the appointment of Michael Grissinger, reflecting ongoing leadership changes in the pharmaceutical sector.
Adicet Bio, Inc. announces its financial results for Q3 2026, emphasizing its commitment to advancing pharmaceutical offerings in a competitive market.
Franklin Templeton has updated its beneficial ownership in Adicet Bio, Inc. to 7.7%, reflecting confidence in the pharmaceutical preparations sector.
683 filing rows loaded from submissions recent.
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-13 | 8-K | 8-K | 5.02 | 0001720580-26-000069 | 001-38359 | 261552285 | 34 | 155951 | 1 | 1 |
| 2026-11-05 | 10-Q | 10-Q | 0001720580-26-000066 | 001-38359 | 261527546 | 34 | 11110294 | 1 | 1 | |
| 2026-11-05 | 8-K | 8-K | 2.02,9.01 | 0001720580-26-000065 | 001-38359 | 261527486 | 34 | 378167 | 1 | 1 |
| 2026-10-28 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000038777-26-000272 | 005-90283 | 261494507 | 34 | 30196 | |||
| 2026-10-23 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0002161951-26-000001 | 005-90283 | 261483166 | 34 | 8666 | |||
| 2026-09-28 | 8-K | 8-K | 7.01,8.01,9.01 | 0001720580-26-000060 | 001-38359 | 261412026 | 34 | 15801832 | 1 | 1 |
| 2026-09-08 | 8-K | 8-K | 7.01,9.01 | 0001720580-26-000056 | 001-38359 | 261365283 | 34 | 18688838 | 1 | 1 |
| 2026-09-01 | 8-K | 8-K | 7.01,9.01 | 0001720580-26-000054 | 001-38359 | 261348497 | 34 | 208922 | 1 | 1 |
| 2026-08-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001231919-26-000916 | 005-90283 | 261282848 | 34 | 15402 | |||
| 2026-08-07 | 4 | 4 | 0001776004-26-000003 | 5570 | ||||||
| 2026-08-05 | 10-Q | 10-Q | 0001720580-26-000050 | 001-38359 | 261243915 | 34 | 10920998 | 1 | 1 | |
| 2026-08-05 | 8-K | 8-K | 2.02,9.01 | 0001720580-26-000049 | 001-38359 | 261243851 | 34 | 361183 | 1 | 1 |
| 2026-06-23 | 4 | 4 | 0001340875-26-000007 | 5606 | ||||||
| 2026-06-23 | 4 | 4 | 0001886986-26-000004 | 5605 | ||||||
| 2026-06-23 | 4 | 4 | 0001265123-26-000001 | 5514 | ||||||
| 2026-06-23 | 4 | 4 | 0001610876-26-000002 | 5553 | ||||||
| 2026-06-23 | 4 | 4 | 0001757601-26-000002 | 5530 | ||||||
| 2026-06-23 | 4 | 4 | 0001762451-26-000002 | 5537 | ||||||
| 2026-06-23 | 4 | 4 | 0001983850-26-000001 | 5518 | ||||||
| 2026-06-23 | 4 | 4 | 0001776004-26-000001 | 5529 | ||||||
| 2026-06-18 | 8-K | 8-K | 5.07 | 0001720580-26-000043 | 001-38359 | 261102407 | 34 | 180317 | 1 | 1 |
| 2026-05-20 | 10-K/A | 10-K/A | 0001720580-26-000042 | 001-38359 | 261004095 | 34 | 3498635 | 1 | 1 | |
| 2026-05-15 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000919574-26-003239 | 005-90283 | 26982853 | 34 | 9021 | |||
| 2026-05-13 | S-8 POS | S-8 POS | 0001720580-26-000038 | 333-249275 | 26974593 | 33 | 182428 | |||
| 2026-05-13 | 10-Q | 10-Q | 0001720580-26-000037 | 001-38359 | 26973955 | 34 | 9751748 | 1 | 1 | |
| 2026-05-13 | 8-K | 8-K | 2.02,9.01 | 0001720580-26-000036 | 001-38359 | 26973151 | 34 | 304835 | 1 | 1 |
| 2026-04-29 | 4 | xslF345X06/form4-04292026_040403.xml | 0001231919-26-000425 | 14326 | ||||||
| 2026-04-29 | ARS | ARS | 0001720580-26-000029 | 001-38359 | 26915957 | 34 | 2859564 | |||
| 2026-04-29 | DEFA14A | DEFA14A | 0001720580-26-000028 | 001-38359 | 26915754 | 34 | 1033965 | 1 | 1 | |
| 2026-04-29 | DEF 14A | DEF 14A | 0001720580-26-000027 | 001-38359 | 26915676 | 34 | 3986368 | 1 | 1 | |
| 2026-04-28 | 8-K | 8-K | 3.02,9.01 | 0001720580-26-000023 | 001-38359 | 26907474 | 34 | 282864 | 1 | 1 |
| 2026-04-13 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001346824-26-000105 | 005-90283 | 26858581 | 34 | 15069 | |||
| 2026-04-13 | 4 | xslF345X06/form4-04132026_090451.xml | 0001231919-26-000337 | 15718 | ||||||
| 2026-04-13 | 3 | xslF345X06/form3-04132026_090419.xml | 0001231919-26-000335 | 12089 | ||||||
| 2026-04-10 | SCHEDULE 13D/A | xslSCHEDULE_13D_X02/primary_doc.xml | 0000947871-26-000427 | 005-90283 | 26856222 | 34 | 49162 | |||
| 2026-04-09 | 4 | xslF345X06/ownership.xml | 0000947871-26-000421 | 30345 | ||||||
| 2026-04-09 | 144 | xsl144X01/primary_doc.xml | 0000947871-26-000420 | 001-38359 | 26852659 | 33 | 4934 | |||
| 2026-04-08 | 144 | xsl144X01/primary_doc.xml | 0000947871-26-000417 | 001-38359 | 26849562 | 33 | 4986 | |||
| 2026-04-07 | 144 | xsl144X01/primary_doc.xml | 0000947871-26-000413 | 001-38359 | 26846228 | 33 | 5056 | |||
| 2026-03-27 | 4 | 4 | 0001519432-26-000002 | 5547 | ||||||
| 2026-03-27 | 4 | 4 | 0001340875-26-000003 | 5550 | ||||||
| 2026-03-27 | 4 | 4 | 0002052749-26-000003 | 5558 | ||||||
| 2026-03-27 | 4 | 4 | 0001643067-26-000002 | 5540 | ||||||
| 2026-03-27 | 4 | 4 | 0001886986-26-000002 | 5546 | ||||||
| 2026-03-23 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-26-000910 | 333-294265 | 26784031 | 33 | 1829 | ||
| 2026-03-19 | CORRESP | filename1.htm | 0001720580-26-000017 | 18405 | ||||||
| 2026-03-18 | UPLOAD | filename1.pdf | 0000000000-26-002754 | 333-294265 | 40117 | |||||
| 2026-03-12 | S-8 | S-8 | 0001720580-26-000014 | 333-294266 | 26749044 | 33 | 346677 | 1 | 1 | |
| 2026-03-12 | S-3 | S-3 | 0001720580-26-000013 | 333-294265 | 26749009 | 33 | 2243685 | 1 | 1 | |
| 2026-03-12 | 10-K | 10-K | 0001720580-26-000008 | 001-38359 | 26748189 | 34 | 17944203 | 1 | 1 | |
| 2026-03-12 | 8-K | 8-K | 2.02,9.01 | 0001720580-26-000006 | 001-38359 | 26748091 | 34 | 309006 | 1 | 1 |
| 2026-02-17 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001346824-26-000031 | 005-90283 | 26641600 | 34 | 15431 | |||
| 2026-02-17 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001214659-26-002017 | 005-90283 | 26641472 | 34 | 14211 | |||
| 2026-02-17 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0000902664-26-001061 | 005-90283 | 26640195 | 34 | 9158 | |||
| 2026-01-29 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0000038777-26-000021 | 005-90283 | 26575860 | 34 | 25474 | |||
| 2026-01-27 | 4 | 4 | 0001193125-26-024755 | 4924 | ||||||
| 2026-01-27 | 4 | 4 | 0001193125-26-024753 | 4918 | ||||||
| 2026-01-27 | 4 | 4 | 0001193125-26-024749 | 6782 | ||||||
| 2026-01-27 | 4 | 4 | 0001193125-26-024746 | 4925 | ||||||
| 2026-01-07 | 8-K | 8-K | 7.01,8.01,9.01 | 0001193125-26-005486 | 001-38359 | 26514079 | 34 | 225155 | 1 | 1 |
| 2025-12-29 | 8-K | 8-K | 5.03,8.01,9.01 | 0001193125-25-332343 | 001-38359 | 251603350 | 34 | 232777 | 1 | 1 |
| 2025-12-19 | 8-K | 8-K | 5.07 | 0001193125-25-326784 | 001-38359 | 251587454 | 34 | 161175 | 1 | 1 |
| 2025-11-17 | DEF 14A | DEF 14A | 0001193125-25-284586 | 001-38359 | 251490991 | 34 | 1685827 | 1 | 1 | |
| 2025-11-05 | PRE 14A | PRE 14A | 0001193125-25-266928 | 001-38359 | 251454031 | 34 | 1681235 | 1 | 1 | |
| 2025-11-05 | 10-Q | 10-Q | 0001193125-25-266880 | 001-38359 | 251453889 | 34 | 10917902 | 1 | 1 | |
| 2025-11-05 | 8-K | 8-K | 2.02,9.01 | 0001193125-25-266860 | 001-38359 | 251453786 | 34 | 348652 | 1 | 1 |
| 2025-10-10 | 4 | xslF345X05/ownership.xml | 0000947871-25-000898 | 26293 | ||||||
| 2025-10-10 | SCHEDULE 13D/A | xslSCHEDULE_13D_X01/primary_doc.xml | 0000947871-25-000897 | 005-90283 | 251389030 | 34 | 48544 | |||
| 2025-10-07 | 8-K | 8-K | 3.01 | 0001193125-25-233427 | 001-38359 | 251379808 | 34 | 156969 | 1 | 1 |
| 2025-10-07 | 8-K | 8-K | 1.01,9.01 | 0001193125-25-232558 | 001-38359 | 251378247 | 34 | 1041495 | 1 | 1 |
| 2025-10-07 | 424B5 | 424B5 | 0001193125-25-232551 | 333-285609 | 251378240 | 33 | 2417460 | |||
| 2025-10-07 | 8-K | 8-K | 8.01,9.01 | 0001193125-25-232539 | 001-38359 | 251378226 | 34 | 19535157 | 1 | 1 |
| 2025-08-07 | 10-Q | 10-Q | 0000950170-25-104978 | 001-38359 | 251193855 | 34 | 11518431 | 1 | 1 | |
| 2025-08-07 | 8-K | 8-K | 2.02,9.01 | 0000950170-25-104969 | 001-38359 | 251193802 | 34 | 336705 | 1 | 1 |
| 2025-07-25 | S-8 | S-8 | 0000950170-25-098771 | 333-288953 | 251151650 | 33 | 326298 | 1 | 1 | |
| 2025-07-23 | 8-K | 8-K | 2.05,8.01,9.01 | 0000950170-25-097881 | 001-38359 | 251143071 | 34 | 304536 | 1 | 1 |
| 2025-06-13 | 4 | 4 | 0000950170-25-086166 | 7460 | ||||||
| 2025-06-13 | 4 | 4 | 0000950170-25-086163 | 7483 | ||||||
| 2025-06-13 | 4 | 4 | 0000950170-25-086160 | 7308 | ||||||
| 2025-06-13 | 4 | 4 | 0000950170-25-086157 | 7448 | ||||||
| 2025-06-13 | 4 | 4 | 0000950170-25-086135 | 7467 | ||||||
| 2025-06-13 | 8-K | 8-K | 5.07 | 0000950170-25-086120 | 001-38359 | 251046329 | 34 | 171977 | 1 | 1 |
| 2025-05-15 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001214659-25-007867 | 005-90283 | 25953321 | 34 | 28705 | |||
| 2025-05-06 | 10-Q | 10-Q | 0000950170-25-064448 | 001-38359 | 25917256 | 34 | 9659106 | 1 | 1 | |
| 2025-05-06 | 8-K | 8-K | 2.02,9.01 | 0000950170-25-064423 | 001-38359 | 25917149 | 34 | 305635 | 1 | 1 |
| 2025-04-29 | ARS | ARS | 0000950170-25-060130 | 001-38359 | 25887671 | 34 | 3324581 | |||
| 2025-04-29 | DEFA14A | DEFA14A | 0000950170-25-060115 | 001-38359 | 25887470 | 34 | 1698722 | 1 | 1 | |
| 2025-04-29 | DEF 14A | DEF 14A | 0000950170-25-060104 | 001-38359 | 25887415 | 34 | 6303033 | 1 | 1 | |
| 2025-04-21 | 4 | 4 | 0000950170-25-056294 | 5391 | ||||||
| 2025-04-21 | 3 | 3 | 0000950170-25-056290 | 14799 | ||||||
| 2025-04-17 | 8-K | 8-K | 5.02,7.01,9.01 | 0000950170-25-054995 | 001-38359 | 25844285 | 34 | 195709 | 1 | 1 |
| 2025-04-11 | 8-K | 8-K | 3.01 | 0000950170-25-053238 | 001-38359 | 25831510 | 34 | 158354 | 1 | 1 |
| 2025-03-26 | S-8 POS | S-8 POS | 0000950170-25-045304 | 333-249275 | 25773720 | 33 | 243742 | |||
| 2025-03-18 | 424B5 | 424B5 | 0000950170-25-041128 | 333-285609 | 25748147 | 33 | 360219 | |||
| 2025-03-14 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-25-000695 | 333-285609 | 25742150 | 33 | 1836 | ||
| 2025-03-12 | CORRESP | filename1.htm | 0000950170-25-037893 | 14243 | ||||||
| 2025-03-11 | UPLOAD | filename1.pdf | 0000000000-25-002651 | 333-285609 | 40095 | |||||
| 2025-03-06 | S-8 | S-8 | 0000950170-25-034851 | 333-285610 | 25716110 | 33 | 402647 | 1 | 1 | |
| 2025-03-06 | S-3 | S-3 | 0000950170-25-034844 | 333-285609 | 25716081 | 33 | 2534069 | |||
| 2025-03-06 | 10-K | 10-K | 0000950170-25-034587 | 001-38359 | 25715167 | 34 | 15800931 | 1 | 1 | |
| 2025-03-06 | 8-K | 8-K | 2.02,9.01 | 0000950170-25-034580 | 001-38359 | 25715128 | 34 | 321565 | 1 | 1 |
| 2025-02-05 | 8-K | 8-K | 8.01 | 0000950170-25-014153 | 001-38359 | 25590844 | 34 | 163376 | 1 | 1 |
| 2025-02-04 | 4 | 4 | 0000950170-25-013611 | 5413 | ||||||
| 2025-02-04 | 4 | 4 | 0000950170-25-013607 | 5410 | ||||||
| 2025-02-04 | 4 | 4 | 0000950170-25-013602 | 5387 | ||||||
| 2025-02-04 | 4 | 4 | 0000950170-25-013596 | 5504 | ||||||
| 2025-02-04 | 4 | 4 | 0000950170-25-013591 | 5414 | ||||||
| 2025-01-28 | 4 | 4 | 0000950170-25-009843 | 7203 | ||||||
| 2025-01-28 | 4 | 4 | 0000950170-25-009839 | 4745 | ||||||
| 2025-01-28 | 4 | 4 | 0000950170-25-009838 | 4771 | ||||||
| 2025-01-28 | 4 | 4 | 0000950170-25-009827 | 4772 | ||||||
| 2025-01-23 | 3 | 3 | 0000950170-25-008323 | 14896 | ||||||
| 2024-12-19 | 8-K | 8-K | 7.01,8.01,9.01 | 0000950170-24-138419 | 001-38359 | 241563244 | 34 | 194186 | 1 | 1 |
| 2024-11-27 | 8-K | 8-K | 1.02 | 0000950170-24-131609 | 001-38359 | 241512361 | 34 | 152009 | 1 | 1 |
| 2024-11-18 | 8-K | 8-K | 7.01,8.01,9.01 | 0000950170-24-127927 | 001-38359 | 241471414 | 34 | 227127 | 1 | 1 |
| 2024-11-15 | 8-K | 8-K | 1.01,9.01 | 0000950170-24-127560 | 001-38359 | 241467745 | 34 | 213427 | 1 | 1 |
| 2024-11-14 | SC 13G/A | SC 13G/A | 0001104659-24-119283 | 005-90283 | 241464717 | 34 | 93012 | |||
| 2024-11-14 | SC 13G/A | formsc13g.htm | 0001493152-24-045800 | 005-90283 | 241461790 | 34 | 88030 | |||
| 2024-11-14 | SC 13G/A | AMENDMENT NO. 2 | 0001214659-24-019102 | 005-90283 | 241461368 | 34 | 136782 | |||
| 2024-11-14 | SC 13G/A | ADICET BIO, INC. | 0000902664-24-006484 | 005-90283 | 241456805 | 34 | 65807 | |||
| 2024-11-13 | SC 13G/A | COWEN FINANCIAL PRODUCTS LLC | 0001085146-24-005617 | 005-90283 | 241453737 | 34 | 27343 | |||
| 2024-11-06 | 10-Q | 10-Q | 0000950170-24-122253 | 001-38359 | 241430828 | 34 | 8282565 | 1 | 1 | |
| 2024-11-06 | 8-K | 8-K | 2.02,9.01 | 0000950170-24-122244 | 001-38359 | 241430790 | 34 | 312115 | 1 | 1 |
| 2024-10-16 | 8-K | 8-K | 7.01,8.01,9.01 | 0000950170-24-114839 | 001-38359 | 241373265 | 34 | 193524 | 1 | 1 |
| 2024-10-08 | SC 13G/A | ACET_SC13GA1.htm | 0001273087-24-000093 | 005-90283 | 241360687 | 34 | 81772 | |||
| 2024-09-30 | 8-K | 8-K | 7.01,8.01,9.01 | 0000950170-24-110166 | 001-38359 | 241336628 | 34 | 190851 | 1 | 1 |
| 2024-09-19 | 8-K | 8-K | 7.01,8.01,9.01 | 0000950170-24-107988 | 001-38359 | 241309070 | 34 | 194061 | 1 | 1 |
| 2024-09-10 | 8-K | 8-K | 8.01 | 0000950170-24-104915 | 001-38359 | 241288730 | 34 | 157163 | 1 | 1 |
| 2024-08-23 | 4 | 4 | 0000950170-24-100180 | 24775 | ||||||
| 2024-08-23 | 4 | 4 | 0000950170-24-100179 | 20522 | ||||||
| 2024-08-23 | 4 | 4 | 0000950170-24-100178 | 8012 | ||||||
| 2024-08-23 | 4 | 4 | 0000950170-24-100176 | 20568 | ||||||
| 2024-08-23 | 4 | 4 | 0000950170-24-100174 | 20396 | ||||||
| 2024-08-23 | 4 | 4 | 0000950170-24-100173 | 16672 | ||||||
| 2024-08-23 | 4 | 4 | 0000950170-24-100165 | 20503 | ||||||
| 2024-08-20 | 4 | 4 | 0000950170-24-099073 | 5400 | ||||||
| 2024-08-20 | 3 | 3 | 0000950170-24-099068 | 16694 | ||||||
| 2024-08-19 | 8-K | 8-K | 5.02,7.01,9.01 | 0000950170-24-098485 | 001-38359 | 241220348 | 34 | 187343 | 1 | 1 |
| 2024-08-13 | 10-Q | 10-Q | 0000950170-24-095745 | 001-38359 | 241198731 | 34 | 7707037 | 1 | 1 | |
| 2024-08-13 | 8-K | 8-K | 2.02,9.01 | 0000950170-24-095744 | 001-38359 | 241198722 | 34 | 282371 | 1 | 1 |
| 2024-07-10 | SC 13G/A | MS AMENDMENT | 0000895421-24-000393 | 005-90283 | 241110041 | 34 | 12903 | |||
| 2024-07-08 | 8-K | 8-K | 7.01,9.01 | 0000950170-24-081943 | 001-38359 | 241103339 | 34 | 174250 | 1 | 1 |
| 2024-06-24 | 8-K | 8-K | 7.01,8.01,9.01 | 0000950170-24-076460 | 001-38359 | 241061956 | 34 | 187307 | 1 | 1 |
| 2024-06-07 | 4 | 4 | 0000950170-24-070632 | 5414 | ||||||
| 2024-06-07 | 4 | 4 | 0000950170-24-070630 | 5386 | ||||||
| 2024-06-07 | 4 | 4 | 0000950170-24-070628 | 5415 | ||||||
| 2024-06-07 | 4 | 4 | 0000950170-24-070619 | 5388 | ||||||
| 2024-06-07 | 4 | 4 | 0000950170-24-070618 | 5414 | ||||||
| 2024-06-07 | 4 | 4 | 0000950170-24-070616 | 16453 | ||||||
| 2024-06-07 | 4 | 4 | 0000950170-24-070613 | 7493 | ||||||
| 2024-06-07 | 4 | 4 | 0000950170-24-070610 | 10057 | ||||||
| 2024-06-07 | 4 | 4 | 0000950170-24-070608 | 7321 | ||||||
| 2024-06-07 | 4 | 4 | 0000950170-24-070605 | 8848 | ||||||
| 2024-06-07 | 4 | 4 | 0000950170-24-070577 | 7460 | ||||||
| 2024-06-07 | 4 | 4 | 0000950170-24-070575 | 7480 | ||||||
| 2024-06-07 | 8-K | 8-K | 5.02,5.03,5.07,9.01 | 0000950170-24-070568 | 001-38359 | 241029182 | 34 | 507240 | 1 | 1 |
| 2024-06-05 | 144 | xsl144X01/primary_doc.xml | 0001972362-24-000846 | 001-38359 | 241023034 | 33 | 4314 | |||
| 2024-06-05 | 8-K | 8-K | 7.01,9.01 | 0000950170-24-069067 | 001-38359 | 241020691 | 34 | 171146 | 1 | 1 |
| 2024-05-14 | 10-Q | 10-Q | 0000950170-24-059507 | 001-38359 | 24944217 | 34 | 7161109 | 1 | 1 | |
| 2024-05-14 | 8-K | 8-K | 2.02,9.01 | 0000950170-24-059496 | 001-38359 | 24944135 | 34 | 245444 | 1 | 1 |
| 2024-05-10 | 8-K | 8-K | 7.01,9.01 | 0000950170-24-057429 | 001-38359 | 24932741 | 34 | 10167100 | 1 | 1 |
| 2024-04-26 | DEFR14A | DEFR14A | 0000950170-24-049136 | 001-38359 | 24883898 | 34 | 3905706 | 1 | 1 | |
| 2024-04-24 | ARS | ARS | 0000950170-24-047195 | 001-38359 | 24866486 | 34 | 3900725 | |||
| 2024-04-23 | DEFA14A | DEFA14A | 0000950170-24-047044 | 001-38359 | 24865637 | 34 | 1382299 | |||
| 2024-04-23 | DEF 14A | DEF 14A | 0000950170-24-047034 | 001-38359 | 24865615 | 34 | 3881905 | 1 | 1 | |
| 2024-04-22 | 8-K | 8-K | 7.01,8.01,9.01 | 0000950170-24-046459 | 001-38359 | 24861582 | 34 | 200925 | 1 | 1 |
| 2024-04-12 | PRE 14A | PRE 14A | 0000950170-24-044147 | 001-38359 | 24842470 | 34 | 2664517 | 1 | 1 | |
| 2024-03-22 | 8-K | 8-K | 1.01,9.01 | 0000950170-24-035366 | 001-38359 | 24775427 | 34 | 591738 | 1 | 1 |
| 2024-03-22 | 424B5 | 424B5 | 0000950170-24-035357 | 333-263587 | 24775334 | 33 | 703024 | |||
| 2024-03-21 | SC 13D/A | AMENDMENT NO. 7 | 0000947871-24-000300 | 005-90283 | 24771853 | 34 | 257698 | |||
| 2024-03-19 | S-8 POS | S-8 POS | 0000950170-24-033524 | 333-249275 | 24763646 | 33 | 165768 | |||
| 2024-03-19 | S-8 | S-8 | 0000950170-24-033502 | 333-278063 | 24763548 | 33 | 167688 | |||
| 2024-03-19 | 10-K | 10-K | 0000950170-24-033482 | 001-38359 | 24763399 | 34 | 12242966 | 1 | 1 | |
| 2024-03-19 | 8-K | 8-K | 2.02,9.01 | 0000950170-24-033476 | 001-38359 | 24763349 | 34 | 301061 | 1 | 1 |
| 2024-02-27 | SC 13G | ACET_SC13G.htm | 0001273087-24-000052 | 005-90283 | 24687301 | 34 | 81865 | |||
| 2024-02-14 | SC 13G/A | acet13ga.htm | 0000935836-24-000201 | 005-90283 | 24638960 | 34 | 44951 | |||
| 2024-02-14 | SC 13G/A | AMENDMENT NO. 1 | 0001214659-24-002857 | 005-90283 | 24637373 | 34 | 87351 | |||
| 2024-02-14 | SC 13G/A | ADICET BIO, INC | 0000902664-24-001558 | 005-90283 | 24632301 | 34 | 63567 | |||
| 2024-02-12 | SC 13G | MS INITIAL | 0000895421-24-000186 | 005-90283 | 24617873 | 34 | 12760 | |||
| 2024-02-07 | SC 13G/A | us0070021086_020724.txt | 0001086364-24-006832 | 005-90283 | 24605718 | 34 | 12569 | |||
| 2024-02-07 | SC 13D/A | SC 13D/A | 0001193125-24-026734 | 005-90283 | 24604767 | 34 | 190465 | |||
| 2024-02-05 | SC 13G | SC 13G | 0001104659-24-010651 | 005-90283 | 24596154 | 34 | 88807 | |||
| 2024-02-02 | SC 13G/A | COWEN FINANCIAL PRODUCTS LLC | 0001085146-24-000635 | 005-90283 | 24589482 | 34 | 27376 | |||
| 2024-01-31 | SC 13G/A | us0070021086_013124.txt | 0001086364-24-005988 | 005-90283 | 24582115 | 34 | 13477 | |||
| 2024-01-29 | SC 13D/A | AMENDMENT NO. 6 | 0000947871-24-000074 | 005-90283 | 24574413 | 34 | 263868 | |||
| 2024-01-26 | 4 | 4 | 0000950170-24-008053 | 26846 | ||||||
| 2024-01-26 | 4 | 4 | 0000950170-24-008052 | 14717 | ||||||
| 2024-01-26 | 4 | 4 | 0000950170-24-008051 | 8887 | ||||||
| 2024-01-26 | 4 | 4 | 0000950170-24-008050 | 8914 | ||||||
| 2024-01-26 | 4 | 4 | 0000950170-24-008049 | 8888 | ||||||
| 2024-01-26 | 4 | 4 | 0000950170-24-008048 | 8915 | ||||||
| 2024-01-26 | 4 | 4 | 0000950170-24-008046 | 10691 | ||||||
| 2024-01-24 | 8-K | 8-K | 1.01,2.02,8.01,9.01 | 0000950170-24-007011 | 001-38359 | 24556928 | 34 | 1168399 | 1 | 1 |
| 2024-01-24 | 424B5 | 424B5 | 0000950170-24-007007 | 333-263587 | 24556913 | 33 | 862857 | |||
| 2024-01-23 | SC 13G/A | Adicet_Bio_Inc.txt | 0000093751-24-000085 | 005-90283 | 24550733 | 34 | 8472 | |||
| 2024-01-22 | 424B5 | 424B5 | 0000950170-24-006074 | 333-263587 | 24549175 | 33 | 852573 | |||
| 2024-01-19 | SC 13G | formsc13g.htm | 0001493152-24-003061 | 005-90283 | 24545598 | 34 | 97046 | |||
| 2024-01-16 | 8-K | 8-K | 7.01,9.01 | 0000950170-24-004403 | 001-38359 | 24533622 | 34 | 23364387 | 1 | 1 |
| 2024-01-04 | 8-K | 8-K | 7.01,8.01,9.01 | 0000950170-24-001490 | 001-38359 | 24509757 | 34 | 638465 | 1 | 1 |
| 2023-11-13 | 8-K | 8-K | 5.02 | 0000950170-23-063062 | 001-38359 | 231399559 | 34 | 163670 | 1 | 1 |
| 2023-11-08 | 10-Q | 10-Q | 0000950170-23-061128 | 001-38359 | 231388025 | 34 | 8636052 | 1 | 1 | |
| 2023-11-08 | 8-K | 8-K | 2.02,9.01 | 0000950170-23-061121 | 001-38359 | 231387982 | 34 | 353137 | 1 | 1 |
| 2023-10-16 | 4 | FORM 4 SUBMISSION | 0001209191-23-052845 | 4918 | ||||||
| 2023-10-03 | 4 | FORM 4 SUBMISSION | 0001209191-23-051473 | 4890 | ||||||
| 2023-10-03 | 4 | FORM 4 SUBMISSION | 0001209191-23-051470 | 4892 | ||||||
| 2023-10-03 | 4 | FORM 4 SUBMISSION | 0001209191-23-051468 | 4919 | ||||||
| 2023-10-02 | 4 | FORM 4 SUBMISSION | 0001209191-23-051259 | 13688 | ||||||
| 2023-09-29 | 144 | xsl144X01/primary_doc.xml | 0001950047-23-004316 | 001-38359 | 231296411 | 33 | 4779 | |||
| 2023-08-16 | 4 | FORM 4 SUBMISSION | 0001209191-23-046103 | 32981 | ||||||
| 2023-08-16 | 4 | FORM 4 SUBMISSION | 0001209191-23-046102 | 33451 | ||||||
| 2023-08-16 | 4 | FORM 4 SUBMISSION | 0001209191-23-046101 | 28411 | ||||||
| 2023-08-16 | 4 | FORM 4 SUBMISSION | 0001209191-23-046100 | 26171 | ||||||
| 2023-08-16 | 4 | FORM 4 SUBMISSION | 0001209191-23-046099 | 26140 | ||||||
| 2023-08-16 | 4 | FORM 4 SUBMISSION | 0001209191-23-046098 | 23610 | ||||||
| 2023-08-16 | 4 | FORM 4 SUBMISSION | 0001209191-23-046097 | 27700 | ||||||
| 2023-08-16 | 4 | FORM 4 SUBMISSION | 0001209191-23-046096 | 27699 | ||||||
| 2023-08-16 | 4 | FORM 4 SUBMISSION | 0001209191-23-046095 | 18294 | ||||||
| 2023-08-16 | 4 | FORM 4 SUBMISSION | 0001209191-23-046094 | 22673 | ||||||
| 2023-08-16 | 4 | FORM 4 SUBMISSION | 0001209191-23-046093 | 22780 | ||||||
| 2023-08-16 | 4 | FORM 4 SUBMISSION | 0001209191-23-046091 | 22845 | ||||||
| 2023-08-16 | 4 | FORM 4 SUBMISSION | 0001209191-23-046090 | 8738 | ||||||
| 2023-08-09 | S-8 POS | S-8 POS | 0000950170-23-040656 | 333-249275 | 231155611 | 33 | 297196 | |||
| 2023-08-09 | S-8 | S-8 | 0000950170-23-040646 | 333-273834 | 231155579 | 33 | 363679 | |||
| 2023-08-09 | 10-Q | 10-Q | 0000950170-23-040631 | 001-38359 | 231155498 | 34 | 9269815 | 1 | 1 | |
| 2023-08-09 | 8-K | 8-K | 2.02,9.01 | 0000950170-23-040617 | 001-38359 | 231155410 | 34 | 385045 | 1 | 1 |
| 2023-07-11 | 4 | FORM 4 SUBMISSION | 0001209191-23-042018 | 5360 | ||||||
| 2023-07-11 | 3 | FORM 3 SUBMISSION | 0001209191-23-042015 | 7509 | ||||||
| 2023-07-11 | 8-K | 8-K | 5.02,7.01,9.01 | 0000950170-23-032449 | 001-38359 | 231081255 | 34 | 206083 | 1 | 1 |
| 2023-06-30 | 4 | FORM 4 SUBMISSION | 0001209191-23-040299 | 4853 | ||||||
| 2023-06-29 | 4 | xslF345X04/ownership.xml | 0000947871-23-000714 | 16145 | ||||||
| 2023-06-29 | 4 | xslF345X04/ownership.xml | 0000947871-23-000713 | 29431 | ||||||
| 2023-06-29 | SC 13D/A | AMENDMENT NO. 5 | 0000947871-23-000710 | 005-90283 | 231057821 | 34 | 242833 | |||
| 2023-06-26 | 8-K | 8-K | 7.01,8.01,9.01 | 0000950170-23-029851 | 001-38359 | 231042337 | 34 | 470684 | 1 | 1 |
| 2023-06-05 | 8-K | 8-K | 1.01,9.01 | 0000950170-23-026406 | 001-38359 | 23993379 | 34 | 218326 | 1 | 1 |
| 2023-06-05 | 8-K | 8-K | 5.02,5.07,9.01 | 0000950170-23-026198 | 001-38359 | 23990462 | 34 | 424750 | 1 | 1 |
| 2023-06-02 | 4 | FORM 4 SUBMISSION | 0001209191-23-033961 | 7795 | ||||||
| 2023-06-02 | 4 | FORM 4 SUBMISSION | 0001209191-23-033960 | 7777 | ||||||
| 2023-06-02 | 4 | FORM 4 SUBMISSION | 0001209191-23-033959 | 7785 | ||||||
| 2023-06-02 | 4 | FORM 4 SUBMISSION | 0001209191-23-033958 | 10359 | ||||||
| 2023-06-02 | 4 | FORM 4 SUBMISSION | 0001209191-23-033957 | 7750 | ||||||
| 2023-06-02 | 4 | FORM 4 SUBMISSION | 0001209191-23-033956 | 7623 | ||||||
| 2023-06-02 | 4 | FORM 4 SUBMISSION | 0001209191-23-033955 | 9978 | ||||||
| 2023-05-18 | 8-K | 8-K | 7.01,8.01,9.01 | 0000950170-23-022865 | 001-38359 | 23933630 | 34 | 225769 | 1 | 1 |
| 2023-05-09 | 10-Q | 10-Q | 0000950170-23-019700 | 001-38359 | 23902283 | 34 | 8291291 | 1 | 1 | |
| 2023-05-09 | 8-K | 8-K | 2.02,9.01 | 0000950170-23-019685 | 001-38359 | 23902168 | 34 | 323462 | 1 | 1 |
| 2023-04-18 | ARS | ARS | 0000950170-23-013298 | 001-38359 | 23827249 | 34 | 2215042 | |||
| 2023-04-18 | DEF 14A | DEF 14A | 0000950170-23-013294 | 001-38359 | 23827202 | 34 | 1656157 | |||
| 2023-04-18 | DEFA14A | DEFA14A | 0000950170-23-013291 | 001-38359 | 23827165 | 34 | 186299 | |||
| 2023-03-15 | S-8 | S-8 | 0000950170-23-008138 | 333-270560 | 23735294 | 33 | 229825 | |||
| 2023-03-15 | 10-K | 10-K | 0000950170-23-008130 | 001-38359 | 23735208 | 34 | 14571857 | 1 | 1 | |
| 2023-03-15 | 8-K | 8-K | 2.02 | 0000950170-23-008122 | 001-38359 | 23735150 | 34 | 381054 | 1 | 1 |
| 2023-03-13 | SC 13G | r38231sc13g.htm | 0001214659-23-003784 | 005-90283 | 23727233 | 34 | 93808 | |||
| 2023-03-10 | 8-K | 8-K | 7.01 | 0000950170-23-007252 | 001-38359 | 23723430 | 34 | 175528 | 1 | 1 |
| 2023-02-17 | 4 | FORM 4 SUBMISSION | 0001209191-23-010936 | 5270 | ||||||
| 2023-02-14 | 5 | FORM 5 SUBMISSION | 0001209191-23-009588 | 20426 | ||||||
| 2023-02-14 | 4 | FORM 4 SUBMISSION | 0001209191-23-009177 | 5272 | ||||||
| 2023-02-14 | SC 13G/A | SC 13G/A | 0001104659-23-021797 | 005-90283 | 23630746 | 34 | 73608 | |||
| 2023-02-14 | SC 13G/A | d9940889_13g-a.htm | 0000919574-23-001489 | 005-90283 | 23625764 | 34 | 163114 | |||
| 2023-02-14 | SC 13G/A | ADICET BIO, INC. | 0000902664-23-001704 | 005-90283 | 23623786 | 34 | 64212 | |||
| 2023-02-13 | SC 13G | us0070021086_021323.txt | 0001306550-23-008656 | 005-90283 | 23617959 | 34 | 13306 | |||
| 2023-02-03 | SC 13G | Adicet_Bio_Inc.txt | 0000093751-23-000157 | 005-90283 | 23585209 | 34 | 8476 | |||
| 2023-01-26 | 4 | FORM 4 SUBMISSION | 0001209191-23-005044 | 7562 | ||||||
| 2023-01-26 | 4 | FORM 4 SUBMISSION | 0001209191-23-005043 | 7591 | ||||||
| 2023-01-26 | 4 | FORM 4 SUBMISSION | 0001209191-23-005041 | 7564 | ||||||
| 2023-01-26 | 4 | FORM 4 SUBMISSION | 0001209191-23-005040 | 7590 | ||||||
| 2023-01-26 | 4 | FORM 4 SUBMISSION | 0001209191-23-005033 | 8476 | ||||||
| 2023-01-11 | SC 13G/A | COWEN FINANCIAL PRODUCTS LLC | 0001085146-23-000071 | 005-90283 | 23522842 | 34 | 27292 | |||
| 2022-12-23 | SC 13G | acet13g.htm | 0000935836-22-000658 | 005-90283 | 221483006 | 34 | 47132 | |||
| 2022-12-12 | 8-K | 8-K | 7.01,8.01,9.01 | 0000950170-22-026329 | 001-38359 | 221456062 | 34 | 797812 | 1 | 1 |
| 2022-12-08 | 8-K | 8-K | 1.01,9.01 | 0000950170-22-026232 | 001-38359 | 221452495 | 34 | 258872 | 1 | 1 |
| 2022-11-15 | 4 | FORM 4 SUBMISSION | 0001209191-22-057005 | 4815 | ||||||
| 2022-11-15 | 4 | FORM 4 SUBMISSION | 0001209191-22-057004 | 7473 | ||||||
| 2022-11-10 | 8-K | 8-K | 7.01,9.01 | 0000950170-22-024573 | 001-38359 | 221378478 | 34 | 5331114 | 1 | 1 |
| 2022-11-09 | 4 | FORM 4 SUBMISSION | 0001209191-22-056193 | 6098 | ||||||
| 2022-11-08 | 424B5 | 424B5 | 0000950170-22-023341 | 333-254193 | 221370014 | 33 | 728831 | |||
| 2022-11-08 | 10-Q | 10-Q | 0000950170-22-023230 | 001-38359 | 221369096 | 34 | 10269503 | 1 | 1 | |
| 2022-11-08 | 8-K | 8-K | 2.02,9.01 | 0000950170-22-023224 | 001-38359 | 221369049 | 34 | 418864 | 1 | 1 |
| 2022-11-04 | 4 | FORM 4 SUBMISSION | 0001209191-22-055828 | 7824 | ||||||
| 2022-11-03 | 8-K | 8-K | 7.01,8.01,9.01 | 0000950170-22-021598 | 001-38359 | 221356461 | 34 | 243785 | 1 | 1 |
| 2022-10-21 | 4 | FORM 4 SUBMISSION | 0001209191-22-054261 | 5338 | ||||||
| 2022-10-17 | SC 13G | SC 13G | 0001104659-22-109351 | 005-90283 | 221314013 | 34 | 80798 | |||
| 2022-10-14 | 4 | FORM 4 SUBMISSION | 0001209191-22-053659 | 10820 | ||||||
| 2022-10-05 | 8-K | 8-K | 8.01,9.01 | 0000950170-22-019282 | 001-38359 | 221294550 | 34 | 347634 | 1 | 1 |
| 2022-10-04 | 4 | FORM 4 SUBMISSION | 0001209191-22-052383 | 5775 | ||||||
| 2022-10-04 | 4 | FORM 4 SUBMISSION | 0001209191-22-052380 | 4888 | ||||||
| 2022-10-04 | 4 | FORM 4 SUBMISSION | 0001209191-22-052376 | 4861 | ||||||
| 2022-10-04 | 4 | FORM 4 SUBMISSION | 0001209191-22-052378 | 4859 | ||||||
| 2022-09-16 | 4 | FORM 4 SUBMISSION | 0001209191-22-050372 | 5701 | ||||||
| 2022-09-13 | 4 | FORM 4 SUBMISSION | 0001209191-22-049721 | 12174 | ||||||
| 2022-08-11 | SC 13D/A | SC 13D/A | 0001193125-22-218665 | 005-90283 | 221156758 | 34 | 229521 | |||
| 2022-08-10 | 10-Q | 10-Q | 0000950170-22-016254 | 001-38359 | 221150388 | 34 | 9448936 | 1 | 1 | |
| 2022-08-10 | 8-K | 8-K | 2.02,9.01 | 0000950170-22-016250 | 001-38359 | 221150374 | 34 | 441110 | 1 | 1 |
| 2022-08-08 | 4 | FORM 4 SUBMISSION | 0001209191-22-044905 | 12083 | ||||||
| 2022-08-08 | 4 | FORM 4 SUBMISSION | 0001209191-22-044904 | 7058 | ||||||
| 2022-08-08 | 4 | FORM 4 SUBMISSION | 0001209191-22-044903 | 7090 | ||||||
| 2022-08-08 | 4 | FORM 4 SUBMISSION | 0001209191-22-044902 | 7087 | ||||||
| 2022-08-08 | 4 | FORM 4 SUBMISSION | 0001209191-22-044901 | 7060 | ||||||
| 2022-08-05 | 4 | FORM 4 SUBMISSION | 0001209191-22-044646 | 4815 | ||||||
| 2022-08-03 | 4 | FORM 4 SUBMISSION | 0001209191-22-044182 | 5338 | ||||||
| 2022-07-07 | 4 | FORM 4 SUBMISSION | 0001209191-22-041499 | 5079 | ||||||
| 2022-06-21 | 8-K | 8-K | 1.01,9.01 | 0000950170-22-011916 | 001-38359 | 221028981 | 34 | 444689 | 1 | 1 |
| 2022-06-06 | 8-K | 8-K | 7.01,8.01,9.01 | 0000950170-22-011219 | 001-38359 | 22998029 | 34 | 502661 | 1 | 1 |
| 2022-06-03 | 4 | FORM 4 SUBMISSION | 0001209191-22-034103 | 5492 | ||||||
| 2022-06-03 | 4 | FORM 4 SUBMISSION | 0001209191-22-034097 | 5524 | ||||||
| 2022-06-03 | 4 | FORM 4 SUBMISSION | 0001209191-22-034092 | 5519 | ||||||
| 2022-06-03 | 4 | FORM 4 SUBMISSION | 0001209191-22-034088 | 5527 | ||||||
| 2022-06-03 | 4 | FORM 4 SUBMISSION | 0001209191-22-034082 | 5537 | ||||||
| 2022-06-03 | 4 | FORM 4 SUBMISSION | 0001209191-22-034079 | 5365 | ||||||
| 2022-06-03 | 4 | FORM 4 SUBMISSION | 0001209191-22-034072 | 5472 | ||||||
| 2022-06-03 | 8-K | 8-K | 5.07 | 0000950170-22-011172 | 001-38359 | 22995019 | 34 | 204339 | 1 | 1 |
| 2022-05-26 | 8-K | 8-K | 7.01,8.01,9.01 | 0000950170-22-010791 | 001-38359 | 22971238 | 34 | 253373 | 1 | 1 |
| 2022-05-12 | 4 | FORM 4 SUBMISSION | 0001209191-22-028567 | 5581 | ||||||
| 2022-05-12 | 10-Q | 10-Q | 0000950170-22-009690 | 001-38359 | 22918192 | 34 | 8986803 | 1 | 1 | |
| 2022-05-12 | 8-K | 8-K | 2.02,9.01 | 0000950170-22-009682 | 001-38359 | 22918084 | 34 | 354935 | 1 | 1 |
| 2022-05-09 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2022-05-09 16:01:00 | 9999999995-22-001370 | 333-263587 | 22907169 | 33 | 1785 | ||
| 2022-05-05 | CORRESP | filename1.htm | 0000950170-22-007926 | 15936 | ||||||
| 2022-05-05 | 8-K | 8-K | 7.01 | 0000950170-22-007552 | 001-38359 | 22893978 | 34 | 200924 | 1 | 1 |
| 2022-04-22 | SC 13G | COWEN FINANCIAL PRODUCTS LLC | 0001085146-22-001519 | 005-90283 | 22845416 | 34 | 27222 | |||
| 2022-04-21 | DEFA14A | DEFA14A | 0000950170-22-005929 | 001-38359 | 22841936 | 34 | 146666 | |||
| 2022-04-21 | DEF 14A | DEF 14A | 0000950170-22-005928 | 001-38359 | 22841901 | 34 | 1049243 | |||
| 2022-04-19 | 8-K | 8-K | 7.01 | 0000950170-22-005777 | 001-38359 | 22833448 | 34 | 188656 | 1 | 1 |
| 2022-04-05 | 4 | FORM 4 SUBMISSION | 0001209191-22-023285 | 26284 | ||||||
| 2022-03-24 | 8-K | 8-K | 1.01,9.01 | 0000950170-22-004583 | 001-38359 | 22767483 | 34 | 540327 | 1 | 1 |
| 2022-03-16 | UPLOAD | filename1.pdf | 0000000000-22-002920 | 40237 | ||||||
| 2022-03-16 | S-3/A | S-3/A | 0001564590-22-010673 | 333-263587 | 22745785 | 33 | 176134 | |||
| 2022-03-16 | S-8 | S-8 031522 | 0001564590-22-010481 | 333-263588 | 22742445 | 33 | 216040 | |||
| 2022-03-15 | S-3 | S-3 | 0001564590-22-010479 | 333-263587 | 22742434 | 33 | 1818152 | |||
| 2022-03-15 | 10-K | 10-K | 0000950170-22-003753 | 001-38359 | 22741300 | 34 | 21087356 | 1 | 1 | |
| 2022-03-15 | 8-K | 8-K | 2.02,9.01 | 0000950170-22-003745 | 001-38359 | 22741184 | 34 | 310599 | 1 | 1 |
| 2022-03-11 | 4 | FORM 4 SUBMISSION | 0001209191-22-018158 | 7754 | ||||||
| 2022-02-17 | 4 | FORM 4 SUBMISSION | 0001209191-22-010952 | 8151 | ||||||
| 2022-02-16 | 4 | FORM 4 SUBMISSION | 0001209191-22-010487 | 7058 | ||||||
| 2022-02-16 | 4 | FORM 4 SUBMISSION | 0001209191-22-010485 | 7088 | ||||||
| 2022-02-16 | 4 | FORM 4 SUBMISSION | 0001209191-22-010483 | 7056 | ||||||
| 2022-02-16 | 4 | FORM 4 SUBMISSION | 0001209191-22-010479 | 7085 | ||||||
| 2022-02-16 | 4 | FORM 4 SUBMISSION | 0001209191-22-010475 | 7087 | ||||||
| 2022-02-14 | 4 | FORM 4 SUBMISSION | 0001209191-22-009417 | 16790 | ||||||
| 2022-02-14 | 5 | FORM 5 SUBMISSION | 0001209191-22-009370 | 15923 | ||||||
| 2022-02-14 | SC 13G/A | d9178689_13g-a.htm | 0000919574-22-001009 | 005-90283 | 22623507 | 34 | 170234 | |||
| 2022-02-03 | 8-K | 8-K | 8.01 | 0000950170-22-000704 | 001-38359 | 22586511 | 34 | 186168 | 1 | 1 |
| 2022-02-01 | 4 | FORM 4 SUBMISSION | 0001209191-22-006142 | 7054 | ||||||
| 2022-02-01 | 4 | FORM 4 SUBMISSION | 0001209191-22-006139 | 7056 | ||||||
| 2022-02-01 | 4 | FORM 4 SUBMISSION | 0001209191-22-006136 | 7086 | ||||||
| 2022-02-01 | 4 | FORM 4 SUBMISSION | 0001209191-22-006134 | 7083 | ||||||
| 2022-02-01 | 4 | FORM 4 SUBMISSION | 0001209191-22-006132 | 7085 | ||||||
| 2022-01-11 | 4 | FORM 4 SUBMISSION | 0001209191-22-002900 | 5529 | ||||||
| 2022-01-11 | 4 | FORM 4 SUBMISSION | 0001209191-22-002895 | 5582 | ||||||
| 2022-01-11 | 4 | FORM 4 SUBMISSION | 0001209191-22-002880 | 5501 | ||||||
| 2022-01-11 | 4 | FORM 4 SUBMISSION | 0001209191-22-002867 | 5503 | ||||||
| 2022-01-11 | 4 | FORM 4 SUBMISSION | 0001209191-22-002860 | 5527 | ||||||
| 2021-12-15 | SC 13G | formsc13g.htm | 0001493152-21-031547 | 005-90283 | 211493922 | 34 | 172425 | |||
| 2021-12-14 | 4 | xslF345X03/ownership.xml | 0000947871-21-001281 | 13180 | ||||||
| 2021-12-14 | 4 | xslF345X03/ownership.xml | 0000947871-21-001280 | 25548 | ||||||
| 2021-12-14 | SC 13D/A | AMENDMENT NO. 4 | 0000947871-21-001279 | 005-90283 | 211492088 | 34 | 242810 | |||
| 2021-12-13 | 4/A | xslF345X03/adicetbio_fm4amdec82021.xml | 0000905718-21-001591 | 6612 | ||||||
| 2021-12-10 | 4 | xslF345X03/adicetbio_fm4dec82021.xml | 0000905718-21-001587 | 6366 | ||||||
| 2021-12-10 | 8-K | 8-K | 1.01,8.01,9.01 | 0000950170-21-005140 | 001-38359 | 211485592 | 34 | 788617 | 1 | 1 |
| 2021-12-09 | 424B5 | 424B5-FINAL | 0001564590-21-059913 | 333-254193 | 211482781 | 33 | 906875 | |||
| 2021-12-07 | 424B5 | 424B5 | 0001564590-21-059603 | 333-254193 | 211476425 | 33 | 945726 | |||
| 2021-12-06 | 8-K | 8-K | 8.01 | 0000950170-21-005044 | 001-38359 | 211472016 | 34 | 207151 | 1 | 1 |
| 2021-11-18 | 4 | FORM 4 SUBMISSION | 0001209191-21-065375 | 5350 | ||||||
| 2021-11-18 | 3 | FORM 3 SUBMISSION | 0001209191-21-065374 | 7578 | ||||||
| 2021-11-18 | 8-K | 8-K | 5.02,7.01,9.01 | 0000950170-21-004750 | 001-38359 | 211422591 | 34 | 205795 | 1 | 1 |
| 2021-11-12 | 8-K | 8-K | 7.01,8.01,9.01 | 0000950170-21-004230 | 001-38359 | 211399541 | 34 | 221553 | 1 | 1 |
| 2021-11-10 | 10-Q | 10-Q | 0000950170-21-004111 | 001-38359 | 211397062 | 34 | 11395822 | 1 | 1 | |
| 2021-11-10 | 8-K | 8-K | 2.02,9.01 | 0000950170-21-004083 | 001-38359 | 211396726 | 34 | 355175 | 1 | 1 |
| 2021-10-29 | 8-K | 8-K | 1.02 | 0000950170-21-002521 | 001-38359 | 211364070 | 34 | 179397 | 1 | 1 |
| 2021-10-25 | 8-K | 8-K | 1.01,9.01 | 0000950170-21-002279 | 001-38359 | 211344550 | 34 | 377825 | 1 | 1 |
| 2021-10-14 | 3/A | FORM 3/A SUBMISSION | 0001209191-21-060487 | 9410 | ||||||
| 2021-10-13 | 3 | FORM 3 SUBMISSION | 0001209191-21-060361 | 4474 | ||||||
| 2021-10-13 | 4 | FORM 4 SUBMISSION | 0001209191-21-060360 | 7797 | ||||||
| 2021-10-05 | 4 | FORM 4 SUBMISSION | 0001209191-21-059577 | 5315 | ||||||
| 2021-10-05 | 4 | FORM 4 SUBMISSION | 0001209191-21-059574 | 5289 | ||||||
| 2021-10-05 | 4 | FORM 4 SUBMISSION | 0001209191-21-059571 | 5287 | ||||||
| 2021-10-05 | 4 | FORM 4 SUBMISSION | 0001209191-21-059569 | 5334 | ||||||
| 2021-09-13 | 8-K | 8-K | 7.01,8.01,9.01 | 0000950170-21-001776 | 001-38359 | 211248682 | 34 | 267629 | 1 | 1 |
| 2021-08-16 | 10-K/A | 10-K/A | 0001564590-21-044668 | 001-38359 | 211179131 | 34 | 439415 | 1 | 1 | |
| 2021-08-12 | S-8 | S-8 | 0001564590-21-044032 | 333-258763 | 211168360 | 33 | 151296 | |||
| 2021-08-12 | 10-Q | 10-Q | 0000950170-21-001381 | 001-38359 | 211168254 | 34 | 9948788 | 1 | 1 | |
| 2021-08-12 | 8-K | 8-K | 2.02,9.01 | 0000950170-21-001371 | 001-38359 | 211167834 | 34 | 327097 | 1 | 1 |
| 2021-07-30 | 8-K | 8-K | 1.02 | 0000950170-21-000624 | 001-38359 | 211132616 | 34 | 174521 | 1 | 1 |
| 2021-07-23 | 8-K | 8-K | 1.01,9.01 | 0001564590-21-037772 | 001-38359 | 211111896 | 34 | 529354 | 1 | 1 |
| 2021-07-01 | 8-K | 8-K | 1.01,9.01 | 0000950170-21-000417 | 001-38359 | 211066050 | 34 | 766242 | 1 | 1 |
| 2021-06-21 | 4 | FORM 4 SUBMISSION | 0001209191-21-042000 | 7248 | ||||||
| 2021-06-17 | 4 | FORM 4 SUBMISSION | 0001209191-21-041630 | 9156 | ||||||
| 2021-06-14 | 4 | FORM 4 SUBMISSION | 0001209191-21-040232 | 5468 | ||||||
| 2021-06-08 | 4 | FORM 4 SUBMISSION | 0001209191-21-039073 | 7667 | ||||||
| 2021-06-07 | 4 | FORM 4 SUBMISSION | 0001209191-21-038758 | 7248 | ||||||
| 2021-05-21 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2021-05-21 16:01:00 | 9999999995-21-002067 | 333-256088 | 21950970 | 33 | 1787 | ||
| 2021-05-21 | 4 | FORM 4 SUBMISSION | 0001209191-21-034929 | 10982 | ||||||
| 2021-05-21 | 424B3 | 424B3 | 0001564590-21-029312 | 333-256088 | 21949272 | 33 | 539844 | |||
| 2021-05-20 | 4 | FORM 4 SUBMISSION | 0001209191-21-034631 | 13622 | ||||||
| 2021-05-19 | CORRESP | filename1.htm | 0001193125-21-166585 | 5797 | ||||||
| 2021-05-18 | UPLOAD | filename1.pdf | 0000000000-21-006269 | 40243 | ||||||
| 2021-05-17 | 8-K/A | 8-K/A | 2.02,5.02,9.01 | 0001564590-21-028402 | 001-38359 | 21930964 | 34 | 262375 | 1 | 1 |
| 2021-05-17 | 10-Q | 10-Q | 0001564590-21-028185 | 001-38359 | 21927596 | 34 | 9605600 | 1 | 1 | |
| 2021-05-17 | 8-K | 8-K | 2.02,5.02,9.01 | 0001564590-21-028180 | 001-38359 | 21927561 | 34 | 257632 | 1 | 1 |
| 2021-05-14 | 4 | FORM 4 SUBMISSION | 0001209191-21-032740 | 9809 | ||||||
| 2021-05-13 | S-3 | S-3 | 0001564590-21-027577 | 333-256088 | 21919974 | 33 | 708054 | |||
| 2021-05-07 | 4 | FORM 4 SUBMISSION | 0001209191-21-030874 | 10985 |
One latest value per concept from companyfacts (386 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| dei | EntityCommonStockSharesOutstanding | Entity Common Stock, Shares Outstanding | shares | 9.36M | 2026-11-03 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 | |
| dei | EntityPublicFloat | Entity Public Float | USD | 50.50M | 2025-06-30 | 2025 | FY | 10-K/A | 2026-05-20 | 0001720580-26-000042 | |
| ecd | NonPeoNeoAvgCompActuallyPaidAmt | NonPeoNeoAvgCompActuallyPaidAmt | USD | 829,146 | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-29 | 0001720580-26-000027 | ||
| ecd | NonPeoNeoAvgTotalCompAmt | NonPeoNeoAvgTotalCompAmt | USD | 1.02M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-29 | 0001720580-26-000027 | ||
| ecd | PeoActuallyPaidCompAmt | PeoActuallyPaidCompAmt | USD | 347,816 | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-29 | 0001720580-26-000027 | ||
| ecd | PeoTotalCompAmt | PeoTotalCompAmt | USD | 1.47M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-29 | 0001720580-26-000027 | ||
| ecd | TotalShareholderRtnAmt | TotalShareholderRtnAmt | USD | 5.89 | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-29 | 0001720580-26-000027 | ||
| srt | FinancingReceivableNonaccrualToOutstandingPercent | FinancingReceivableNonaccrualToOutstandingPercent | pure | 1 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-15 | 0000950170-22-003753 | |
| us-gaap | AccountsPayableCurrent | Accounts Payable, Current | USD | 2.70M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 | |
| us-gaap | AccountsReceivableRelatedPartiesCurrent | Accounts Receivable, Related Parties, Current | USD | 0 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-15 | 0000950170-23-008130 | |
| us-gaap | AccretionAmortizationOfDiscountsAndPremiumsInvestments | Accretion (Amortization) of Discounts and Premiums, Investments | USD | 1.93M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 |
| us-gaap | AccruedLiabilitiesAndOtherLiabilities | Accrued Liabilities and Other Liabilities | USD | 11.45M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 | |
| us-gaap | AccruedLiabilitiesCurrent | Accrued Liabilities, Current | USD | 1.10M | 2020-06-30 | 2020 | Q2 | 10-Q | 2020-07-30 | 0001564590-20-034835 | |
| us-gaap | AccruedProfessionalFeesCurrentAndNoncurrent | Accrued Professional Fees | USD | 1.03M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 | |
| us-gaap | AccumulatedAmortizationDeferredFinanceCosts | Accumulated Amortization, Debt Issuance Costs | USD | 0 | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-08-12 | 0000950170-21-001381 | |
| us-gaap | AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment | Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | USD | 30.97M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 | |
| us-gaap | AccumulatedOtherComprehensiveIncomeLossNetOfTax | Accumulated Other Comprehensive Income (Loss), Net of Tax | USD | -175,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 | |
| us-gaap | AdditionalPaidInCapital | Additional Paid in Capital | USD | 175.63M | 2018-12-31 | 2018 | FY | 10-K | 2019-03-18 | 0001564590-19-008262 | |
| us-gaap | AdditionalPaidInCapitalCommonStock | Additional Paid in Capital, Common Stock | USD | 778.05M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 | |
| us-gaap | AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation | Share-based Payment Arrangement, Decrease for Tax Withholding Obligation | USD | 1.35M | 2022-07-01 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-08 | 0000950170-22-023230 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock | Adjustments to Additional Paid in Capital, Increase in Carrying Amount of Redeemable Preferred Stock | USD | -1.38M | 2017-01-01 | 2017-12-31 | 2019 | FY | 10-K | 2020-03-12 | 0001564590-20-010474 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue | APIC, Share-based Payment Arrangement, Increase for Cost Recognition | USD | 1.51M | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs | USD | 600,000 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001720580-26-000008 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalWarrantIssued | Adjustments to Additional Paid in Capital, Warrant Issued | USD | 22,000 | 2026-04-01 | 2026-06-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 |
| us-gaap | AdministrativeFeesExpense | Administrative Fees Expense | USD | 10.00M | 2024-01-01 | 2024-12-31 | 2026 | Q2 | 10-Q | 2026-08-05 | 0001720580-26-000050 |
| us-gaap | AllocatedShareBasedCompensationExpense | Share-based Payment Arrangement, Expense | USD | 4.25M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 |
| us-gaap | AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnits | Dilutive Securities, Effect on Basic Earnings Per Share, Options and Restrictive Stock Units | USD | 5.38B | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-12 | 0000950170-22-009690 |
| us-gaap | AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares | 1.66M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 |
| us-gaap | AreaOfRealEstateProperty | Area of Real Estate Property | sqft | 9,501 | 2019-04-01 | 2022 | FY | 10-K | 2023-03-15 | 0000950170-23-008130 | |
| us-gaap | AssetImpairmentCharges | Asset Impairment Charges | USD | 0 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-15 | 0000950170-22-003753 |
| us-gaap | Assets | Assets | USD | 128.95M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 | |
| us-gaap | AssetsCurrent | Assets, Current | USD | 103.44M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 | |
| us-gaap | AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 | |
| us-gaap | AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax | USD | 175,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 | |
| us-gaap | AvailableForSaleDebtSecuritiesAmortizedCostBasis | Debt Securities, Available-for-sale, Amortized Cost | USD | 74.01M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 | |
| us-gaap | AvailableForSaleSecuritiesAmortizedCost | Available-for-sale Securities, Amortized Cost Basis | USD | 10.26M | 2020-12-31 | 2020 | FY | 10-K | 2021-03-12 | 0001564590-21-012664 | |
| us-gaap | AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate | Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, Fair Value | USD | 92.52M | 2018-09-30 | 2018 | Q3 | 10-Q | 2018-11-13 | 0001564590-18-029327 | |
| us-gaap | AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost | Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, Year One | USD | 10.26M | 2020-12-31 | 2020 | FY | 10-K | 2021-03-12 | 0001564590-21-012664 | |
| us-gaap | AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue | Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One | USD | 10.28M | 2020-12-31 | 2020 | FY | 10-K | 2021-03-12 | 0001564590-21-012664 | |
| us-gaap | AvailableForSaleSecuritiesDebtSecurities | Debt Securities, Available-for-sale | USD | 73.83M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 | |
| us-gaap | AvailableForSaleSecuritiesDebtSecuritiesCurrent | Debt Securities, Available-for-sale, Current | USD | 0 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-15 | 0000950170-22-003753 | |
| us-gaap | AvailableForSaleSecuritiesDebtSecuritiesNoncurrent | Debt Securities, Available-for-sale, Noncurrent | USD | 0 | 2020-12-31 | 2021 | FY | 10-K | 2022-03-15 | 0000950170-22-003753 | |
| us-gaap | BusinessAcquisitionsProFormaNetIncomeLoss | Business Acquisition, Pro Forma Net Income (Loss) | USD | -35.76M | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-12 | 0001564590-21-012664 |
| us-gaap | BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 | Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-15 | 0000950170-23-008130 |
| us-gaap | BusinessCombinationContingentConsiderationLiability | Business Combination, Contingent Consideration, Liability | USD | 980,000 | 2020-12-31 | 2021 | FY | 10-K | 2022-03-15 | 0000950170-22-003753 | |
| us-gaap | BusinessCombinationStepAcquisitionEquityInterestInAcquireePercentage | Business Combination, Step Acquisition, Equity Interest in Acquiree, Percentage | pure | 0.75 | 2020-09-15 | 2021 | Q2 | 10-Q | 2021-08-12 | 0000950170-21-001381 | |
| us-gaap | CapitalExpendituresIncurredButNotYetPaid | Capital Expenditures Incurred but Not yet Paid | USD | 28,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 |
| us-gaap | CashAcquiredFromAcquisition | Cash Acquired from Acquisition | USD | 64.11M | 2020-01-01 | 2020-12-31 | 2021 | FY | 10-K | 2022-03-15 | 0000950170-22-003753 |
| us-gaap | CashAndCashEquivalentsAtCarryingValue | Cash and Cash Equivalents, at Carrying Value | USD | 27.11M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 | |
| us-gaap | CashAndCashEquivalentsPeriodIncreaseDecrease | Cash and Cash Equivalents, Period Increase (Decrease) | USD | 16.58M | 2019-01-01 | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-05 | 0001564590-19-040353 |
| us-gaap | CashCashEquivalentsAndShortTermInvestments | Cash, Cash Equivalents, and Short-term Investments | USD | 91.50M | 2019-12-31 | 2019 | FY | 10-K | 2020-03-12 | 0001564590-20-010474 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | USD | 29.68M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | USD | -12.11M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 |
| us-gaap | ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 | Class of Warrant or Right, Exercise Price of Warrants or Rights | USD/shares | 0 | 2026-04-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 | |
| us-gaap | ClassOfWarrantOrRightOutstanding | Class of Warrant or Right, Outstanding | shares | 0 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-15 | 0000950170-23-008130 | |
| us-gaap | CommonStockCapitalSharesReservedForFutureIssuance | Common Stock, Capital Shares Reserved for Future Issuance | shares | 3.42M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 | |
| us-gaap | CommonStockDividendsPerShareCashPaid | Common Stock, Dividends, Per Share, Cash Paid | USD/shares | 0 | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-12 | 0001564590-20-010474 |
| us-gaap | CommonStockDividendsPerShareDeclared | Common Stock, Dividends, Per Share, Declared | USD/shares | 0 | 2020-01-01 | 2020-12-31 | 2024 | FY | 10-K | 2025-03-06 | 0000950170-25-034587 |
| us-gaap | CommonStockParOrStatedValuePerShare | Common Stock, Par or Stated Value Per Share | USD/shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 | |
| us-gaap | CommonStockSharesAuthorized | Common Stock, Shares Authorized | shares | 300.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 | |
| us-gaap | CommonStockSharesIssued | Common Stock, Shares, Issued | shares | 9.59M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 | |
| us-gaap | CommonStockSharesOutstanding | Common Stock, Shares, Outstanding | shares | 9.36M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 | |
| us-gaap | CommonStockSharesSubscribedButUnissued | Common Stock, Shares Subscribed but Unissued | shares | 4.38M | 2025-10-07 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 | |
| us-gaap | CommonStockValue | Common Stock, Value, Issued | USD | 1,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 | |
| us-gaap | ComprehensiveIncomeNetOfTax | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | USD | -60.76M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 |
| us-gaap | ConstructionInProgressGross | Construction in Progress, Gross | USD | 500,000 | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-08 | 0000950170-23-061128 | |
| us-gaap | ConstructionPayableCurrentAndNoncurrent | Construction Payable | USD | 13.80M | 2022-03-18 | 2022 | FY | 10-K | 2023-03-15 | 0000950170-23-008130 | |
| us-gaap | ContractWithCustomerLiabilityCurrent | Contract with Customer, Liability, Current | USD | 0 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-15 | 0000950170-23-008130 | |
| us-gaap | ContractWithCustomerLiabilityNoncurrent | Contract with Customer, Liability, Noncurrent | USD | 10.89M | 2019-12-31 | 2020 | FY | 10-K | 2021-03-12 | 0001564590-21-012664 | |
| us-gaap | ConversionOfStockAmountConverted1 | Conversion of Stock, Amount Converted | USD | 2.92M | 2020-01-01 | 2020-12-31 | 2021 | FY | 10-K | 2022-03-15 | 0000950170-22-003753 |
| us-gaap | ConvertiblePreferredStockSharesIssuedUponConversion | Convertible Preferred Stock, Shares Issued upon Conversion | shares | 12.05M | 2019-12-31 | 2020 | FY | 10-K | 2021-03-12 | 0001564590-21-012664 | |
| us-gaap | CostsAndExpenses | Costs and Expenses | USD | 85.46M | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-12 | 0001564590-20-010474 |
| us-gaap | CurrentFederalTaxExpenseBenefit | Current Federal Tax Expense (Benefit) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001720580-26-000008 |
| us-gaap | CurrentForeignTaxExpenseBenefit | Current Foreign Tax Expense (Benefit) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001720580-26-000008 |
| us-gaap | CurrentIncomeTaxExpenseBenefit | Current Income Tax Expense (Benefit) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001720580-26-000008 |
| us-gaap | CurrentStateAndLocalTaxExpenseBenefit | Current State and Local Tax Expense (Benefit) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001720580-26-000008 |
| us-gaap | CustomerAdvancesCurrent | Customer Advances, Current | USD | 500,000 | 2018-09-30 | 2018 | Q3 | 10-Q | 2018-11-13 | 0001564590-18-029327 | |
| us-gaap | DebtConversionConvertedInstrumentAmount1 | Debt Conversion, Converted Instrument, Amount | USD | 114.08M | 2020-01-01 | 2020-12-31 | 2021 | FY | 10-K | 2022-03-15 | 0000950170-22-003753 |
| us-gaap | DeferredCostsCurrent | Deferred Costs, Current | USD | 929,000 | 2017-12-31 | 2018 | FY | 10-K | 2019-03-18 | 0001564590-19-008262 | |
| us-gaap | DeferredFederalIncomeTaxExpenseBenefit | Deferred Federal Income Tax Expense (Benefit) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001720580-26-000008 |
| us-gaap | DeferredFinanceCostsGross | Debt Issuance Costs, Gross | USD | 400,000 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-15 | 0000950170-23-008130 | |
| us-gaap | DeferredFinanceCostsNet | Debt Issuance Costs, Net | USD | 100,000 | 2021-03-31 | 2021 | Q1 | 10-Q | 2021-05-17 | 0001564590-21-028185 | |
| us-gaap | DeferredForeignIncomeTaxExpenseBenefit | Deferred Foreign Income Tax Expense (Benefit) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001720580-26-000008 |
| us-gaap | DeferredIncomeTaxesAndTaxCredits | Deferred Income Taxes and Tax Credits | USD | 28,000 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-19 | 0000950170-24-033482 |
| us-gaap | DeferredIncomeTaxExpenseBenefit | Deferred Income Tax Expense (Benefit) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001720580-26-000008 |
| us-gaap | DeferredIncomeTaxLiabilities | Deferred Tax Liabilities, Gross | USD | 125,000 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-12 | 0001564590-21-012664 | |
| us-gaap | DeferredIncomeTaxLiabilitiesNet | Deferred Income Tax Liabilities, Net | USD | 125,000 | 2020-12-31 | 2021 | FY | 10-K | 2022-03-15 | 0000950170-22-003753 | |
| us-gaap | DeferredOfferingCosts | Deferred Offering Costs | USD | 0 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-18 | 0001564590-19-008262 | |
| us-gaap | DeferredRentCreditNoncurrent | Deferred Rent Credit, Noncurrent | USD | 234,000 | 2019-12-31 | 2020 | FY | 10-K | 2021-03-12 | 0001564590-21-012664 | |
| us-gaap | DeferredRevenueRevenueRecognized1 | Deferred Revenue, Revenue Recognized | USD | 0 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-19 | 0000950170-24-033482 |
| us-gaap | DeferredStateAndLocalIncomeTaxExpenseBenefit | Deferred State and Local Income Tax Expense (Benefit) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001720580-26-000008 |
| us-gaap | DeferredTaxAssetsDeferredIncome | Deferred Tax Assets, Deferred Income | USD | 0 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-19 | 0000950170-24-033482 | |
| us-gaap | DeferredTaxAssetsGoodwillAndIntangibleAssets | Deferred Tax Assets, Goodwill and Intangible Assets | USD | 541,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001720580-26-000008 | |
| us-gaap | DeferredTaxAssetsGross | Deferred Tax Assets, Gross | USD | 143.13M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001720580-26-000008 | |
| us-gaap | DeferredTaxAssetsInProcessResearchAndDevelopment | Deferred Tax Assets, in Process Research and Development | USD | 26,000 | 2022-12-31 | 2023 | FY | 10-K | 2024-03-19 | 0000950170-24-033482 | |
| us-gaap | DeferredTaxAssetsLiabilitiesNet | Deferred Tax Assets, Net | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001720580-26-000008 | |
| us-gaap | DeferredTaxAssetsNet | Deferred Tax Assets, Net of Valuation Allowance | USD | 2.60M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001720580-26-000008 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwards | Deferred Tax Assets, Operating Loss Carryforwards | USD | 103.03M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001720580-26-000008 | |
| us-gaap | DeferredTaxAssetsOtherComprehensiveLoss | Deferred Tax Assets, Other Comprehensive Loss | USD | 11,000 | 2018-12-31 | 2019 | FY | 10-K | 2020-03-12 | 0001564590-20-010474 | |
| us-gaap | DeferredTaxAssetsTaxCreditCarryforwardsResearch | Deferred Tax Assets, Tax Credit Carryforwards, Research | USD | 4.15M | 2019-12-31 | 2019 | FY | 10-K | 2020-03-12 | 0001564590-20-010474 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost | USD | 3.04M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001720580-26-000008 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals | Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals | USD | 1.04M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001720580-26-000008 | |
| us-gaap | DeferredTaxAssetsValuationAllowance | Deferred Tax Assets, Valuation Allowance | USD | 140.53M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001720580-26-000008 | |
| us-gaap | DeferredTaxLiabilitiesOtherComprehensiveIncome | Deferred Tax Liabilities, Other Comprehensive Income | USD | 13,000 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-12 | 0001564590-20-010474 | |
| us-gaap | DefinedContributionPlanEmployerDiscretionaryContributionAmount | Defined Contribution Plan, Employer Discretionary Contribution Amount | USD | 1.10M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001720580-26-000008 |
| us-gaap | Depreciation | Depreciation | USD | 3.58M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 |
| us-gaap | DepreciationAndAmortization | Depreciation, Depletion and Amortization, Nonproduction | USD | 3.58M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 |
| us-gaap | DevelopmentInProcess | Development in Process | USD | 1.19M | 2020-12-31 | 2021 | FY | 10-K | 2022-03-15 | 0000950170-22-003753 | |
| us-gaap | DilutiveSecuritiesEffectOnBasicEarningsPerShareOther | Dilutive Securities, Effect on Basic Earnings Per Share, Dilutive Convertible Securities | USD | 538.66M | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-12 | 0000950170-22-009690 |
| us-gaap | DividendsPayableCurrentAndNoncurrent | Dividends Payable | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 | |
| us-gaap | DueToRelatedPartiesCurrent | Due to Related Parties, Current | USD | 0 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-18 | 0001564590-19-008262 | |
| us-gaap | EarningsPerShareBasic | Earnings Per Share, Basic | USD/shares | -5.62 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 |
| us-gaap | EarningsPerShareBasicAndDiluted | Earnings Per Share, Basic and Diluted | USD/shares | -2 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-15 | 0000950170-22-003753 |
| us-gaap | EarningsPerShareDiluted | Earnings Per Share, Diluted | USD/shares | -5.62 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 |
| us-gaap | EffectiveIncomeTaxRateContinuingOperations | Effective Income Tax Rate Reconciliation, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001720580-26-000008 |
| us-gaap | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | pure | 0.21 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001720580-26-000008 |
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent | pure | -0.178 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001720580-26-000008 |
| us-gaap | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent | pure | -0.006 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001720580-26-000008 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent | pure | -0.001 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001720580-26-000008 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent | pure | -0.025 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001720580-26-000008 |
| us-gaap | EffectiveIncomeTaxRateReconciliationOtherAdjustments | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001720580-26-000008 |
| us-gaap | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Percent | pure | -0.033 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001720580-26-000008 |
| us-gaap | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001720580-26-000008 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxCredits | Effective Income Tax Rate Reconciliation, Tax Credit, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001720580-26-000008 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxCreditsForeign | Effective Income Tax Rate Reconciliation, Tax Credit, Foreign, Percent | pure | 0 | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-12 | 0001564590-21-012664 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxCreditsOther | Effective Income Tax Rate Reconciliation, Tax Credit, Other, Percent | pure | -0.001 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001720580-26-000008 |
| us-gaap | EmployeeBenefitsAndShareBasedCompensation | Employee Benefits and Share-based Compensation | USD | 200,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 |
| us-gaap | EmployeeRelatedLiabilitiesCurrent | Employee-related Liabilities, Current | USD | 4.90M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 | |
| us-gaap | EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions | Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount | USD | 0 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-12 | 0001564590-21-012664 | |
| us-gaap | EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount | USD | 4.10M | 2021-12-31 | 2021 | FY | 10-K | 2022-03-15 | 0000950170-22-003753 | |
| us-gaap | EquityMethodInvestmentOwnershipPercentage | Equity Method Investment, Ownership Percentage | pure | 0.25 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-15 | 0000950170-22-003753 | |
| us-gaap | FairValueAdjustmentOfWarrants | Fair Value Adjustment of Warrants | USD | 897,000 | 2020-01-01 | 2020-12-31 | 2021 | FY | 10-K | 2022-03-15 | 0000950170-22-003753 |
| us-gaap | FairValueAssetsLevel1ToLevel2TransfersAmount | Fair Value, Assets, Level 1 to Level 2 Transfers, Amount | USD | 0 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-12 | 0001564590-20-010474 | |
| us-gaap | FairValueAssetsLevel2ToLevel1TransfersAmount | Fair Value, Assets, Level 2 to Level 1 Transfers, Amount | USD | 0 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-12 | 0001564590-20-010474 | |
| us-gaap | FairValueLiabilitiesLevel1ToLevel2TransfersAmount | Fair Value, Liabilities, Level 1 to Level 2 Transfers, Amount | USD | 0 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-12 | 0001564590-20-010474 | |
| us-gaap | FairValueLiabilitiesLevel2ToLevel1TransfersAmount | Fair Value, Liabilities, Level 2 to Level 1 Transfers, Amount | USD | 0 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-12 | 0001564590-20-010474 | |
| us-gaap | FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net | USD | 0 | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-12 | 0001564590-20-010474 |
| us-gaap | FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Transfers, Net | USD | 0 | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-12 | 0001564590-20-010474 |
| us-gaap | FairValueOfAssetsAcquired | Fair Value of Assets Acquired | USD | 84.14M | 2020-01-01 | 2020-12-31 | 2021 | FY | 10-K | 2022-03-15 | 0000950170-22-003753 |
| us-gaap | FinanceLeaseInterestExpense | Finance Lease, Interest Expense | USD | 23,000 | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 |
| us-gaap | FinanceLeaseLiability | Finance Lease, Liability | USD | 806,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 | |
| us-gaap | FinanceLeaseLiabilityCurrent | Finance Lease, Liability, Current | USD | 174,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 | |
| us-gaap | FinanceLeaseLiabilityNoncurrent | Finance Lease, Liability, Noncurrent | USD | 632,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 | |
| us-gaap | FinanceLeaseLiabilityPaymentsDue | Finance Lease, Liability, Payment, Due | USD | 1.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 | |
| us-gaap | FinanceLeaseLiabilityPaymentsDueInNextRollingTwelveMonths | Finance Lease, Liability, Payments, Due in Next Rolling Twelve Months | USD | 250,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 | |
| us-gaap | FinanceLeaseLiabilityPaymentsDueInRollingAfterYearFive | Finance Lease, Liability, Payments, Due in Rolling after Year Five | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001720580-26-000008 | |
| us-gaap | FinanceLeaseLiabilityPaymentsDueInRollingYearFive | Finance Lease, Liability, Payments, Due in Rolling Year Five | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 | |
| us-gaap | FinanceLeaseLiabilityPaymentsDueInRollingYearFour | Finance Lease, Liability, Payments, Due in Rolling Year Four | USD | 250,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 | |
| us-gaap | FinanceLeaseLiabilityPaymentsDueInRollingYearThree | Finance Lease, Liability, Payments, Due in Rolling Year Three | USD | 250,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 | |
| us-gaap | FinanceLeaseLiabilityPaymentsDueInRollingYearTwo | Finance Lease, Liability, Payments, Due in Rolling Year Two | USD | 250,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 | |
| us-gaap | FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear | Finance Lease, Liability, to be Paid, Remainder of Fiscal Year | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 | |
| us-gaap | FinanceLeaseLiabilityUndiscountedExcessAmount | Finance Lease, Liability, Undiscounted Excess Amount | USD | 194,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 | |
| us-gaap | FinanceLeasePrincipalPayments | Finance Lease, Principal Payments | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 |
| us-gaap | FinanceLeaseRightOfUseAsset | Finance Lease, Right-of-Use Asset, after Accumulated Amortization | USD | 854,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 | |
| us-gaap | FinanceLeaseRightOfUseAssetAmortization | Finance Lease, Right-of-Use Asset, Amortization | USD | 200,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 |
| us-gaap | FinanceLeaseWeightedAverageDiscountRatePercent | Finance Lease, Weighted Average Discount Rate, Percent | pure | 0.1 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 | |
| us-gaap | GainLossOnDispositionOfAssets1 | Gain (Loss) on Disposition of Assets | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 |
| us-gaap | GainLossOnDispositionOfIntangibleAssets | Gain (Loss) on Disposition of Intangible Assets | USD | 200,000 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-15 | 0000950170-23-008130 |
| us-gaap | GainsLossesOnSalesOfAssets | Gain (Loss) on Disposition of Assets for Financial Service Operations | USD | 100,000 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-15 | 0000950170-23-008130 |
| us-gaap | GeneralAndAdministrativeExpense | General and Administrative Expense | USD | 12.11M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 |
| us-gaap | Goodwill | Goodwill | USD | 0 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-19 | 0000950170-24-033482 | |
| us-gaap | GoodwillImpairedAccumulatedImpairmentLoss | Goodwill, Impaired, Accumulated Impairment Loss | USD | 0 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-06 | 0000950170-25-034587 | |
| us-gaap | GoodwillImpairmentLoss | Goodwill, Impairment Loss | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-06 | 0000950170-25-034587 |
| us-gaap | ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill | Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001720580-26-000008 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | USD | -60.34M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 |
| us-gaap | IncomeTaxesPaid | Income Taxes Paid | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-15 | 0000950170-23-008130 |
| us-gaap | IncomeTaxesReceivable | Income Taxes Receivable, Current | USD | 0 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-15 | 0000950170-22-003753 | |
| us-gaap | IncomeTaxExaminationPenaltiesAndInterestAccrued | Income Tax Examination, Penalties and Interest Accrued | USD | 0 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-12 | 0001564590-20-010474 | |
| us-gaap | IncomeTaxExpenseBenefit | Income Tax Expense (Benefit) | USD | 144,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 |
| us-gaap | IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount | USD | 20.79M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001720580-26-000008 |
| us-gaap | IncomeTaxReconciliationChangeInEnactedTaxRate | Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount | USD | 2.20M | 2017-01-01 | 2017-12-31 | 2019 | FY | 10-K | 2020-03-12 | 0001564590-20-010474 |
| us-gaap | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount | USD | 715,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001720580-26-000008 |
| us-gaap | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount | USD | -24.53M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001720580-26-000008 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseOther | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount | USD | 103,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001720580-26-000008 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount | USD | 2.92M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001720580-26-000008 |
| us-gaap | IncomeTaxReconciliationOtherAdjustments | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001720580-26-000008 |
| us-gaap | IncomeTaxReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001720580-26-000008 |
| us-gaap | IncomeTaxReconciliationTaxCredits | Effective Income Tax Rate Reconciliation, Tax Credit, Amount | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001720580-26-000008 |
| us-gaap | IncreaseDecreaseInAccountsPayable | Increase (Decrease) in Accounts Payable | USD | -2.03M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 |
| us-gaap | IncreaseDecreaseInAccountsReceivable | Increase (Decrease) in Accounts Receivable | USD | 10.00M | 2020-01-01 | 2020-06-30 | 2021 | Q2 | 10-Q | 2021-08-12 | 0000950170-21-001381 |
| us-gaap | IncreaseDecreaseInAccountsReceivableRelatedParties | Increase (Decrease) in Accounts Receivable, Related Parties | USD | 0 | 2023-01-01 | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-08 | 0000950170-23-061128 |
| us-gaap | IncreaseDecreaseInAccruedLiabilities | Increase (Decrease) in Accrued Liabilities | USD | -4.39M | 2020-01-01 | 2020-06-30 | 2020 | Q2 | 10-Q | 2020-07-30 | 0001564590-20-034835 |
| us-gaap | IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities | USD | -2.05M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 |
| us-gaap | IncreaseDecreaseInConstructionPayables | Increase (Decrease) in Construction Payables | USD | 8.80M | 2023-01-01 | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-08 | 0000950170-23-061128 |
| us-gaap | IncreaseDecreaseInContractWithCustomerLiability | Increase (Decrease) in Contract with Customer, Liability | USD | 0 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-19 | 0000950170-24-033482 |
| us-gaap | IncreaseDecreaseInCustomerAdvances | Increase (Decrease) in Customer Advances | USD | 500,000 | 2018-01-01 | 2018-09-30 | 2018 | Q3 | 10-Q | 2018-11-13 | 0001564590-18-029327 |
| us-gaap | IncreaseDecreaseInDeferredLiabilities | Increase (Decrease) in Deferred Liabilities | USD | -119,000 | 2020-01-01 | 2020-09-30 | 2021 | Q3 | 10-Q | 2021-11-10 | 0000950170-21-004111 |
| us-gaap | IncreaseDecreaseInOtherNoncurrentAssets | Increase (Decrease) in Other Noncurrent Assets | USD | 1,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 |
| us-gaap | IncreaseDecreaseInOtherNoncurrentLiabilities | Increase (Decrease) in Other Noncurrent Liabilities | USD | -9,000 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-15 | 0000950170-22-003753 |
| us-gaap | IncreaseDecreaseInOtherOperatingLiabilities | Increase (Decrease) in Other Operating Liabilities | USD | 1,000 | 2020-01-01 | 2020-09-30 | 2020 | Q3 | 10-Q | 2020-11-05 | 0001564590-20-051476 |
| us-gaap | IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets | Increase (Decrease) in Prepaid Expense and Other Assets | USD | 102,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 |
| us-gaap | IncreaseDecreaseInRestrictedCash | Increase (Decrease) in Restricted Cash | USD | 161,000 | 2019-01-01 | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-05 | 0001564590-19-040353 |
| us-gaap | IntangibleAssetsNetExcludingGoodwill | Intangible Assets, Net (Excluding Goodwill) | USD | 0 | 2021-12-31 | 2022 | FY | 10-K | 2023-03-15 | 0000950170-23-008130 | |
| us-gaap | InterestAndOtherIncome | Interest and Other Income | USD | 3.48M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 |
| us-gaap | InterestExpense | Interest Expense | USD | 68,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 |
| us-gaap | InterestIncomeOperating | Interest Income, Operating | USD | 3.48M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 |
| us-gaap | InterestReceivableCurrent | Interest Receivable, Current | USD | 297,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 | |
| us-gaap | InvestmentIncomeNonoperating | Investment Income, Nonoperating | USD | 2.82M | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-12 | 0001564590-20-010474 |
| us-gaap | LeaseAndRentalExpense | Operating Leases, Rent Expense | USD | 200,000 | 2020-01-01 | 2020-03-31 | 2021 | Q1 | 10-Q | 2021-05-17 | 0001564590-21-028185 |
| us-gaap | LeaseCost | Lease, Cost | USD | 858,000 | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 |
| us-gaap | LeaseholdImprovementsGross | Leasehold Improvements, Gross | USD | 18.40M | 2022-12-31 | 2022 | FY | 10-K | 2023-03-15 | 0000950170-23-008130 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDue | Lessee, Operating Lease, Liability, to be Paid | USD | 13.01M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive | Lessee, Operating Lease, Liability, Payments, Due after Rolling Year Five | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001720580-26-000008 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive | Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Five | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour | Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Four | USD | 662,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree | Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Three | USD | 3.91M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo | Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Two | USD | 3.81M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths | Lessee, Operating Lease, Liability, Payments, Due Next Rolling Twelve Months | USD | 3.71M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear | Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year | USD | 921,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 | |
| us-gaap | LesseeOperatingLeaseLiabilityUndiscountedExcessAmount | Lessee, Operating Lease, Liability, Undiscounted Excess Amount | USD | 1.72M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 | |
| us-gaap | LettersOfCreditOutstandingAmount | Letters of Credit Outstanding, Amount | USD | 200,000 | 2019-04-30 | 2019 | FY | 10-K | 2020-03-12 | 0001564590-20-010474 | |
| us-gaap | Liabilities | Liabilities | USD | 26.25M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 | |
| us-gaap | LiabilitiesAndStockholdersEquity | Liabilities and Equity | USD | 128.95M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 | |
| us-gaap | LiabilitiesCurrent | Liabilities, Current | USD | 17.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 | |
| us-gaap | LitigationReserve | Estimated Litigation Liability | USD | 0 | 2020-03-31 | 2020 | Q1 | 10-Q | 2020-05-07 | 0001564590-20-022817 | |
| us-gaap | LitigationSettlementExpense | Litigation Settlement, Expense | USD | 200,000 | 2020-10-01 | 2020-12-31 | 2021 | FY | 10-K | 2022-03-15 | 0000950170-22-003753 |
| us-gaap | LoansReceivableBasisSpreadOnVariableRate | Loans Receivable, Basis Spread on Variable Rate | pure | 0.05 | 2020-04-28 | 2022 | FY | 10-K | 2023-03-15 | 0000950170-23-008130 | |
| us-gaap | MarketableSecurities | Marketable Securities | USD | 0 | 2023-12-31 | 2024 | FY | 10-K | 2025-03-06 | 0000950170-25-034587 | |
| us-gaap | MarketableSecuritiesCurrent | Marketable Securities, Current | USD | 0 | 2020-06-30 | 2020 | Q2 | 10-Q | 2020-07-30 | 0001564590-20-034835 | |
| us-gaap | NetCashProvidedByUsedInFinancingActivities | Net Cash Provided by (Used in) Financing Activities | USD | -6,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 |
| us-gaap | NetCashProvidedByUsedInFinancingActivitiesContinuingOperations | Net Cash Provided by (Used in) Financing Activities, Continuing Operations | USD | 89.94M | 2018-01-01 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-10 | 0001564590-18-012984 |
| us-gaap | NetCashProvidedByUsedInInvestingActivities | Net Cash Provided by (Used in) Investing Activities | USD | 47.13M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 |
| us-gaap | NetCashProvidedByUsedInInvestingActivitiesContinuingOperations | Net Cash Provided by (Used in) Investing Activities, Continuing Operations | USD | -278,000 | 2018-01-01 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-10 | 0001564590-18-012984 |
| us-gaap | NetCashProvidedByUsedInOperatingActivities | Net Cash Provided by (Used in) Operating Activities | USD | -59.23M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 |
| us-gaap | NetCashProvidedByUsedInOperatingActivitiesContinuingOperations | Net Cash Provided by (Used in) Operating Activities, Continuing Operations | USD | -7.30M | 2018-01-01 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-10 | 0001564590-18-012984 |
| us-gaap | NetIncomeLoss | Net Income (Loss) Attributable to Parent | USD | -60.48M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 |
| us-gaap | NetIncomeLossAvailableToCommonStockholdersBasic | Net Income (Loss) Available to Common Stockholders, Basic | USD | -60.48M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 |
| us-gaap | NetIncomeLossAvailableToCommonStockholdersDiluted | Net Income (Loss) Available to Common Stockholders, Diluted | USD | -60.48M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 |
| us-gaap | NoninterestExpenseOfferingCost | Noninterest Expense Offering Cost | USD | 91.70M | 2024-01-23 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 | |
| us-gaap | NotesReduction | Notes Reduction | USD | 0 | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-12 | 0000950170-22-009690 |
| us-gaap | NumberOfOperatingSegments | Number of Operating Segments | Segment | 1 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-15 | 0000950170-22-003753 |
| us-gaap | NumberOfReportableSegments | Number of Reportable Segments | Segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 |
| us-gaap | OperatingExpenses | Operating Expenses | USD | 63.67M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 |
| us-gaap | OperatingIncomeLoss | Operating Income (Loss) | USD | -63.67M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 |
| us-gaap | OperatingLeaseCost | Operating Lease, Cost | USD | 2.70M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 |
| us-gaap | OperatingLeaseLiability | Operating Lease, Liability | USD | 11.29M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 | |
| us-gaap | OperatingLeaseLiabilityCurrent | Operating Lease, Liability, Current | USD | 2.67M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 | |
| us-gaap | OperatingLeaseLiabilityNoncurrent | Operating Lease, Liability, Noncurrent | USD | 8.62M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 | |
| us-gaap | OperatingLeasePayments | Operating Lease, Payments | USD | 100,000 | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-05 | 0001720580-26-000050 |
| us-gaap | OperatingLeasePaymentsUse | Operating Lease, Payments, Use | USD | 773,000 | 2023-07-01 | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-08 | 0000950170-23-061128 |
| us-gaap | OperatingLeaseRightOfUseAsset | Operating Lease, Right-of-Use Asset | USD | 8.93M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDue | Operating Leases, Future Minimum Payments Due | USD | 27.02M | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-08 | 0000950170-23-061128 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueCurrent | Operating Leases, Future Minimum Payments Due, Next Twelve Months | USD | 5.01M | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-08 | 0000950170-23-061128 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInFiveYears | Operating Leases, Future Minimum Payments, Due in Five Years | USD | 2.88M | 2019-12-31 | 2020 | FY | 10-K | 2021-03-12 | 0001564590-21-012664 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInFourYears | Operating Leases, Future Minimum Payments, Due in Four Years | USD | 12.09M | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-08 | 0000950170-23-061128 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInThreeYears | Operating Leases, Future Minimum Payments, Due in Three Years | USD | 4.01M | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-08 | 0000950170-23-061128 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInTwoYears | Operating Leases, Future Minimum Payments, Due in Two Years | USD | 4.66M | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-08 | 0000950170-23-061128 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueThereafter | Operating Leases, Future Minimum Payments, Due Thereafter | USD | 13.75M | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-10 | 0000950170-21-004111 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear | Operating Leases, Future Minimum Payments, Remainder of Fiscal Year | USD | 1.24M | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-08 | 0000950170-23-061128 | |
| us-gaap | OperatingLeasesRentExpenseMinimumRentals | Operating Leases, Rent Expense, Minimum Rentals | USD | 600,000 | 2019-04-01 | 2019-04-30 | 2019 | FY | 10-K | 2020-03-12 | 0001564590-20-010474 |
| us-gaap | OperatingLeasesRentExpenseSubleaseRentals1 | Operating Leases, Rent Expense, Sublease Rentals | USD | 3.50M | 2021-07-19 | 2022 | FY | 10-K | 2023-03-15 | 0000950170-23-008130 | |
| us-gaap | OperatingLeaseWeightedAverageDiscountRatePercent | Operating Lease, Weighted Average Discount Rate, Percent | pure | 0.069 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 | |
| us-gaap | OtherAccruedLiabilitiesCurrent | Other Accrued Liabilities, Current | USD | 140,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 | |
| us-gaap | OtherAssetImpairmentCharges | Other Asset Impairment Charges | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001720580-26-000008 |
| us-gaap | OtherAssetsCurrent | Other Assets, Current | USD | 490,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 | |
| us-gaap | OtherAssetsNoncurrent | Other Assets, Noncurrent | USD | 80,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 | |
| us-gaap | OtherComprehensiveIncomeLossBeforeTax | Other Comprehensive Income (Loss), before Tax | USD | -277,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 |
| us-gaap | OtherComprehensiveIncomeLossNetOfTax | Other Comprehensive Income (Loss), Net of Tax | USD | -70,000 | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 |
| us-gaap | OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-15 | 0000950170-23-008130 |
| us-gaap | OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-15 | 0000950170-23-008130 |
| us-gaap | OtherLiabilities | Other Liabilities | USD | 115,000 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-15 | 0000950170-22-003753 | |
| us-gaap | OtherLiabilitiesNoncurrent | Other Liabilities, Noncurrent | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 | |
| us-gaap | OtherNoncashExpense | Other Noncash Expense | USD | 2.16M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 |
| us-gaap | OtherNonoperatingIncomeExpense | Other Nonoperating Income (Expense) | USD | -83,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 |
| us-gaap | OtherOperatingIncomeExpenseNet | Other Operating Income (Expense), Net | USD | 151,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 |
| us-gaap | OtherShortTermInvestments | Other Short-term Investments | USD | 73.83M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 | |
| us-gaap | PaymentsForRepurchaseOfCommonStock | Payments for Repurchase of Common Stock | USD | 15.00M | 2021-02-01 | 2021-02-28 | 2021 | FY | 10-K | 2022-03-15 | 0000950170-22-003753 |
| us-gaap | PaymentsForRestructuring | Payments for Restructuring | USD | 500,000 | 2020-01-01 | 2020-03-31 | 2020 | Q1 | 10-Q | 2020-05-07 | 0001564590-20-022817 |
| us-gaap | PaymentsOfDebtIssuanceCosts | Payments of Debt Issuance Costs | USD | 22,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 |
| us-gaap | PaymentsRelatedToTaxWithholdingForShareBasedCompensation | Payment, Tax Withholding, Share-based Payment Arrangement | USD | 3,000 | 2026-04-01 | 2026-06-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 |
| us-gaap | PaymentsToAcquireMarketableSecurities | Payments to Acquire Marketable Securities | USD | 5.70M | 2020-01-01 | 2020-12-31 | 2021 | FY | 10-K | 2022-03-15 | 0000950170-22-003753 |
| us-gaap | PaymentsToAcquirePropertyPlantAndEquipment | Payments to Acquire Property, Plant, and Equipment | USD | 295,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 |
| us-gaap | PreferredStockParOrStatedValuePerShare | Preferred Stock, Par or Stated Value Per Share | USD/shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 | |
| us-gaap | PreferredStockSharesAuthorized | Preferred Stock, Shares Authorized | shares | 10.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 | |
| us-gaap | PreferredStockSharesIssued | Preferred Stock, Shares Issued | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 | |
| us-gaap | PreferredStockSharesOutstanding | Preferred Stock, Shares Outstanding | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 | |
| us-gaap | PreferredStockValue | Preferred Stock, Value, Issued | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 | |
| us-gaap | PrepaidExpenseAndOtherAssetsCurrent | Prepaid Expense and Other Assets, Current | USD | 2.50M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 | |
| us-gaap | PrepaidExpenseCurrent | Prepaid Expense, Current | USD | 535,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 | |
| us-gaap | PrepaidInsurance | Prepaid Insurance | USD | 128,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 | |
| us-gaap | PrepaidRent | Prepaid Rent | USD | 221,000 | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-08 | 0000950170-23-061128 | |
| us-gaap | PrepaidTaxes | Prepaid Taxes | USD | 76,000 | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-08 | 0000950170-23-061128 | |
| us-gaap | ProceedsFromIncomeTaxRefunds | Proceeds from Income Tax Refunds | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-15 | 0000950170-23-008130 |
| us-gaap | ProceedsFromIssuanceInitialPublicOffering | Proceeds from Issuance Initial Public Offering | USD | 43.36M | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-15 | 0000950170-23-008130 |
| us-gaap | ProceedsFromIssuanceOfCommonStock | Proceeds from Issuance of Common Stock | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001720580-26-000008 |
| us-gaap | ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock | Proceeds from Issuance of Redeemable Convertible Preferred Stock | USD | 76.92M | 2019-01-01 | 2019-12-31 | 2020 | FY | 10-K | 2021-03-12 | 0001564590-21-012664 |
| us-gaap | ProceedsFromIssuanceOfWarrants | Proceeds from Issuance of Warrants | USD | 75.17M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001720580-26-000008 |
| us-gaap | ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities | Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-15 | 0000950170-23-008130 |
| us-gaap | ProceedsFromOtherShortTermDebt | Proceeds from Other Short-term Debt | USD | 100,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 |
| us-gaap | ProceedsFromSaleAndMaturityOfMarketableSecurities | Proceeds from Sale and Maturity of Marketable Securities | USD | 2.75M | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-15 | 0000950170-22-003753 |
| us-gaap | ProceedsFromSaleOfPropertyPlantAndEquipment | Proceeds from Sale of Property, Plant, and Equipment | USD | 118,000 | 2019-01-01 | 2019-12-31 | 2020 | FY | 10-K | 2021-03-12 | 0001564590-21-012664 |
| us-gaap | ProceedsFromStockOptionsExercised | Proceeds from Stock Options Exercised | USD | 2,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 |
| us-gaap | ProceedsFromStockPlans | Proceeds from Stock Plans | USD | 82,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 |
| us-gaap | ProfessionalAndContractServicesExpense | Professional and Contract Services Expense | USD | 5.91M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 |
| us-gaap | ProfitLoss | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | USD | -60.48M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 |
| us-gaap | PropertyPlantAndEquipmentGross | Property, Plant and Equipment, Gross | USD | 44.03M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 | |
| us-gaap | PropertyPlantAndEquipmentNet | Property, Plant and Equipment, Net | USD | 13.07M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 | |
| us-gaap | ResearchAndDevelopmentExpense | Research and Development Expense | USD | 51.56M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 |
| us-gaap | ResearchAndDevelopmentInProcess | Research and Development in Process | USD | 1.00M | 2023-01-01 | 2023-03-31 | 2023 | Q1 | 10-Q | 2023-05-09 | 0000950170-23-019700 |
| us-gaap | RestrictedCash | Restricted Cash | USD | 2.60M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 | |
| us-gaap | RestrictedCashNoncurrent | Restricted Cash, Noncurrent | USD | 2.57M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 | |
| us-gaap | RestructuringAndRelatedCostExpectedCostRemaining1 | Restructuring and Related Cost, Expected Cost Remaining | USD | 96,000 | 2020-03-31 | 2020 | Q1 | 10-Q | 2020-05-07 | 0001564590-20-022817 | |
| us-gaap | RestructuringAndRelatedCostIncurredCost | Restructuring and Related Cost, Incurred Cost | USD | 800,000 | 2022-01-01 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-08 | 0000950170-22-023230 |
| us-gaap | RestructuringAndRelatedCostNumberOfPositionsEliminated | Restructuring and Related Cost, Number of Positions Eliminated | Employee | 0 | 2020-01-01 | 2020-06-30 | 2020 | Q2 | 10-Q | 2020-07-30 | 0001564590-20-034835 |
| us-gaap | RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent | Restructuring and Related Cost, Number of Positions Eliminated, Period Percent | pure | 0.22 | 2019-01-01 | 2019-12-31 | 2020 | Q2 | 10-Q | 2020-07-30 | 0001564590-20-034835 |
| us-gaap | RestructuringCharges | Restructuring Charges | USD | 100,000 | 2020-01-01 | 2020-06-30 | 2020 | Q2 | 10-Q | 2020-07-30 | 0001564590-20-034835 |
| us-gaap | RetainedEarningsAccumulatedDeficit | Retained Earnings (Accumulated Deficit) | USD | -675.18M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 | |
| us-gaap | RevenueFromRelatedParties | Revenue from Related Parties | USD | 0 | 2023-01-01 | 2023-03-31 | 2023 | Q1 | 10-Q | 2023-05-09 | 0000950170-23-019700 |
| us-gaap | RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability | Right-of-Use Asset Obtained in Exchange for Finance Lease Liability | USD | 4,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 |
| us-gaap | RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability | USD | 0 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-19 | 0000950170-24-033482 |
| us-gaap | SaleOfStockConsiderationReceivedOnTransaction | Sale of Stock, Consideration Received on Transaction | USD | 94.20M | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-15 | 0000950170-22-003753 |
| us-gaap | SaleOfStockConsiderationReceivedPerTransaction | Sale of Stock, Consideration Received Per Transaction | USD | 128.80M | 2021-02-01 | 2021-02-28 | 2021 | FY | 10-K | 2022-03-15 | 0000950170-22-003753 |
| us-gaap | SaleOfStockNumberOfSharesIssuedInTransaction | Sale of Stock, Number of Shares Issued in Transaction | shares | 7.19M | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-15 | 0000950170-22-003753 |
| us-gaap | SaleOfStockPricePerShare | Sale of Stock, Price Per Share | USD/shares | 16 | 2025-10-07 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 | |
| us-gaap | SecurityDepositLiability | Security Deposit Liability | USD | 100,000 | 2021-07-19 | 2022 | FY | 10-K | 2023-03-15 | 0000950170-23-008130 | |
| us-gaap | ShareBasedCompensation | Share-based Payment Arrangement, Noncash Expense | USD | 4.25M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage | Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage | pure | 0.75 | 2020-07-14 | 2020 | FY | 10-K | 2021-03-12 | 0001564590-21-012664 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPricePurchaseDate | Share-based Compensation Arrangement by Share-based Payment Award, Discount from Market Price, Purchase Date | pure | 0.06 | 2025-10-07 | 2025 | FY | 10-K | 2026-03-12 | 0001720580-26-000008 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period | shares | 50,138 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value | USD/shares | 7.04 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number | shares | 65,461 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value | USD/shares | 37.81 | 2025-12-31 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate | pure | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum | pure | 0.92 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum | pure | 0.9 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum | pure | 0.051 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum | pure | 0.036 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized | Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized | shares | 362,503 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-10 | 0000950170-21-004111 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant | Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant | shares | 560,000 | 2021-10-21 | 2022 | Q2 | 10-Q | 2022-08-10 | 0000950170-22-016254 | |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value | USD | 30,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number | shares | 554,361 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price | USD/shares | 38.56 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value | USD | 100,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001720580-26-000008 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period | shares | 210,524 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures | shares | 110,000 | 2026-06-01 | 2026-06-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | shares | 1.04M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares | Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Number of Shares | shares | 9,237 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Weighted Average Grant Date Fair Value | USD/shares | 15.3 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price | USD/shares | 11.98 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value | USD | 226,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | shares | 1.59M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price | USD/shares | 19.91 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value | USD | 226,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number | shares | 1.59M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price | USD/shares | 19.91 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 | |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares | shares | 22,282 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value | USD/shares | 53.83 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost | Share-based Payment Arrangement, Plan Modification, Incremental Cost | USD | 300,000 | 2025-01-01 | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-05 | 0001193125-25-266880 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price | USD/shares | 7.04 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price | USD/shares | 30.23 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | USD/shares | 7.1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 |
| us-gaap | SharesIssuedPricePerShare | Shares Issued, Price Per Share | USD/shares | 15.04 | 2025-10-07 | 2025 | FY | 10-K | 2026-03-12 | 0001720580-26-000008 | |
| us-gaap | ShortTermInvestments | Short-term Investments | USD | 96.58M | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-06 | 0000950170-24-122253 | |
| us-gaap | ShortTermLeaseCost | Short-term Lease, Cost | USD | 34,000 | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 |
| us-gaap | StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants | Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants | USD | 220.89M | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-12 | 0000950170-22-009690 |
| us-gaap | StockholdersEquity | Stockholders' Equity Attributable to Parent | USD | 102.70M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 | |
| us-gaap | StockholdersEquityNoteStockSplitConversionRatio1 | Stockholders' Equity Note, Stock Split, Conversion Ratio | pure | 0.124 | 2020-09-15 | 2020 | Q3 | 10-Q | 2020-11-05 | 0001564590-20-051476 | |
| us-gaap | StockIssuedDuringPeriodSharesOther | Stock Issued During Period, Shares, Other | shares | 100,731 | 2022-04-30 | 2022 | FY | 10-K | 2023-03-15 | 0000950170-23-008130 | |
| us-gaap | StockIssuedDuringPeriodSharesRestrictedStockAwardGross | Stock Issued During Period, Shares, Restricted Stock Award, Gross | shares | 0 | 2019-01-01 | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-05 | 0001564590-19-040353 |
| us-gaap | StockIssuedDuringPeriodSharesReverseStockSplits | Stock Issued During Period, Shares, Reverse Stock Splits | shares | 0 | 2020-09-15 | 2020 | Q3 | 10-Q | 2020-11-05 | 0001564590-20-051476 | |
| us-gaap | StockIssuedDuringPeriodSharesStockOptionsExercised | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | shares | 257 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 |
| us-gaap | StockIssuedDuringPeriodValueConversionOfConvertibleSecurities | Stock Issued During Period, Value, Conversion of Convertible Securities | USD | 114.08M | 2020-01-01 | 2020-12-31 | 2021 | FY | 10-K | 2022-03-15 | 0000950170-22-003753 |
| us-gaap | StockIssuedDuringPeriodValueEmployeeStockPurchasePlan | Stock Issued During Period, Value, Employee Stock Purchase Plan | USD | 82,000 | 2026-04-01 | 2026-06-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 |
| us-gaap | StockIssuedDuringPeriodValueNewIssues | Stock Issued During Period, Value, New Issues | USD | 238.00M | 2021-01-01 | 2021-12-31 | 2022 | FY | 10-K | 2023-03-15 | 0000950170-23-008130 |
| us-gaap | StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures | Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures | USD | 1,000 | 2019-01-01 | 2019-03-31 | 2020 | Q1 | 10-Q | 2020-05-07 | 0001564590-20-022817 |
| us-gaap | StockIssuedDuringPeriodValueStockOptionsExercised | Stock Issued During Period, Value, Stock Options Exercised | USD | 1,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001720580-26-000008 |
| us-gaap | StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased | Stock Repurchase Program, Number of Shares Authorized to be Repurchased | shares | 1.15M | 2021-02-28 | 2021 | FY | 10-K | 2022-03-15 | 0000950170-22-003753 | |
| us-gaap | SubleaseIncome | Sublease Income | USD | 400,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 |
| us-gaap | TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxExpenseBenefit | Tax Cuts and Jobs Act, Change in Tax Rate, Income Tax Expense (Benefit) | USD | 0 | 2017-12-22 | 2019 | FY | 10-K | 2020-03-12 | 0001564590-20-010474 | |
| us-gaap | TemporaryEquityAccretionToRedemptionValue | Temporary Equity, Accretion to Redemption Value | USD | 0 | 2017-01-01 | 2017-12-31 | 2018 | FY | 10-K | 2019-03-18 | 0001564590-19-008262 |
| us-gaap | TemporaryEquityCarryingAmountAttributableToParent | Temporary Equity, Carrying Amount, Attributable to Parent | USD | 114.08M | 2019-12-31 | 2020 | FY | 10-K | 2021-03-12 | 0001564590-21-012664 | |
| us-gaap | TemporaryEquityLiquidationPreference | Temporary Equity, Liquidation Preference | USD | 128.19M | 2019-12-31 | 2020 | FY | 10-K | 2021-03-12 | 0001564590-21-012664 | |
| us-gaap | TemporaryEquitySharesAuthorized | Temporary Equity, Shares Authorized | shares | 99.36M | 2019-12-31 | 2020 | FY | 10-K | 2021-03-12 | 0001564590-21-012664 | |
| us-gaap | UnrecognizedTaxBenefits | Unrecognized Tax Benefits | USD | 32.10M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001720580-26-000008 | |
| us-gaap | UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions | Unrecognized Tax Benefits, Decrease Resulting from Current Period Tax Positions | USD | 5.73M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-12 | 0001720580-26-000008 |
| us-gaap | UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions | Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions | USD | 2,000 | 2022-01-01 | 2022-12-31 | 2023 | FY | 10-K | 2024-03-19 | 0000950170-24-033482 |
| us-gaap | UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense | Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense | USD | 0 | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-12 | 0001564590-20-010474 |
| us-gaap | UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions | Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-06 | 0000950170-25-034587 |
| us-gaap | VariableLeaseCost | Variable Lease, Cost | USD | 0 | 2022-01-01 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-08 | 0000950170-22-023230 |
| us-gaap | WarrantsAndRightsOutstanding | Warrants and Rights Outstanding | USD | 2.90M | 2020-09-15 | 2020 | FY | 10-K | 2021-03-12 | 0001564590-21-012664 | |
| us-gaap | WeightedAverageLimitedPartnershipUnitsOutstandingDiluted | Weighted Average Limited Partnership Units Outstanding, Diluted | shares | 10.75M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 |
| us-gaap | WeightedAverageNumberOfDilutedSharesOutstanding | Weighted Average Number of Shares Outstanding, Diluted | shares | 10.75M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 |
| us-gaap | WeightedAverageNumberOfShareOutstandingBasicAndDiluted | Weighted Average Number of Shares Outstanding, Basic and Diluted | shares | 30.95M | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-15 | 0000950170-22-003753 |
| us-gaap | WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation | Weighted Average Number of Shares, Common Stock Subject to Repurchase or Cancellation | shares | 9,344 | 2019-01-01 | 2019-12-31 | 2020 | FY | 10-K | 2021-03-12 | 0001564590-21-012664 |
| us-gaap | WeightedAverageNumberOfSharesIssuedBasic | Weighted Average Number of Shares Issued, Basic | shares | 10.75M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 |
| us-gaap | WeightedAverageNumberOfSharesOutstandingBasic | Weighted Average Number of Shares Outstanding, Basic | shares | 10.75M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001720580-26-000066 |